Retention of urine

R18_RETEN_URINE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R33 Hospital discharge: ICD-9 — 7882 Hospital discharge: ICD-8 — 7861 Cause of death: ICD-10 — R33 Cause of death: ICD-9 — 7882 Cause of death: ICD-8 — 7861 2 out of 7 registries used, show all original rules.	17631
4. Check minimum number of events None	17631
5. Include endpoints None	17631
6. Filter based on genotype QC (FinnGen only)	17121

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
Special: URINERETENTION
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R30-R39
Name in latin: Retentio urinae

NAME	R18_RETEN_URINE
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R33
HD_ICD_9	7882
HD_ICD_8	7861
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R33
COD_ICD_9	7882
COD_ICD_8	7861
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Retention of urine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	130594	30375	98621
Only index persons	106312	25977	80335
Unadjusted period prevalence (%)
Whole population	2.30	0.87	2.76
Only index persons	2.55	0.95	3.07
Median age at first event (years)
Whole population	71.99	69.19	72.80
Only index persons	70.90	67.12	72.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	17121	4034	13087
Unadjusted period prevalence (%)	4.92	1.43	6.00
Median age at first event (years)	69.54	60.83	72.22

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17628: Matched controls
144649

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G04BD12

ATC

mirabegron; oral

2.6

323.3

2298

8017

N21.0

ICD-10 Finland

Calculus in bladder

9.0

323.0

444

416

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.1

321.7

753

1265

C61

ICD-10 Finland

Malignant neoplasm of prostate

2.3

318.8

3138

12669

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

54.2

311.5

209

N99.1

ICD-10 Finland

Postprocedural urethral stricture

14.5

308.2

314

181

G04CB01

ATC

finasteride; oral

2.6

307.7

4117

15017

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

8.1

307.7

7354

11764

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

307.7

1766

4623

SPAT1168

SPAT

Catheterisation training

22.2

307.7

371

140

U28

ICPC

Limited function/disability (U)

13.3

307.7

573

364

G04CB02

ATC

dutasteride; oral

2.7

307.7

2660

8908

WX320

NOMESCO Finland

Spinalanesthesy

2.4

307.7

5108

20871

TKC22

NOMESCO Finland

Catheterisation instruction

41.6

307.7

2337

529

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

7.5

307.7

807

914

KCD02

NOMESCO Finland

Transurethral resection of bladder

5.3

307.7

781

1258

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

12.0

307.7

547

386

J01EA01

ATC

trimethoprim; systemic

4.5

307.7

6603

16974

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

5.6

307.7

5042

9723

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

36.7

307.7

260

N30.0

ICD-10 Finland

Acute cystitis

4.8

307.7

4067

8570

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

307.7

3105

11565

R33

ICD-10 Finland

Retention of urine

10783.3

307.7

17291

685

R30.0

ICD-10 Finland

Dysuria

5.6

307.7

818

1247

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

11.5

307.7

388

283

KED52

NOMESCO Finland

Visual laser resection of prostate

8.3

307.7

708

725

L28

ICPC

Limited function/disability (L)

2.3

307.7

3880

15512

UKC02

NOMESCO Finland

Cystoscopy

13.6

307.7

8407

9090

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

307.7

2822

10314

R39.1

ICD-10 Finland

Other difficulties with micturition

12.7

307.7

1295

894

C03CA01

ATC

furosemide; systemic

2.0

307.7

7351

37892

N02AA05

ATC

oxycodone; systemic

2.2

307.7

4077

17100

N30.9

ICD-10 Finland

Cystitis, unspecified

5.5

307.7

1736

2804

N32.0

ICD-10 Finland

Bladder-neck obstruction

11.8

307.7

470

334

KED22

NOMESCO Finland

Transurethral resection of prostate

12.6

307.7

4570

3899

AA1AD

NOMESCO Finland

CT of head and brain

2.0

307.7

5663

28099

Z93.5

ICD-10 Finland

Cystostomy status

90.4

307.7

239

XKC03

NOMESCO Finland

Water cystometry

8.7

307.7

929

923

SPAT1262

SPAT

Handing over of treatment supplies

2.4

307.7

4173

16732

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

5.3

307.7

776

1254

U07

ICPC

Urine symptom/complaint other

6.2

307.7

2574

3887

XJH00

NOMESCO Finland

Transanal ultrasonography

3.9

307.7

2402

5648

J01MA02

ATC

ciprofloxacin; systemic

4.0

307.7

10477

38950

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

5.1

307.7

4117

8211

A06AD11

ATC

lactulose; oral

2.5

307.7

3861

14647

XKD00

NOMESCO Finland

Uroflowmetry

7.6

307.7

8399

15446

Z43.5

ICD-10 Finland

Attention to cystostomy

124.4

307.7

685

R32

ICD-10 Finland

Unspecified urinary incontinence

8.7

307.7

533

515

U13

ICPC

Bladder symptom/complaint other

7.1

307.7

897

1084

G04CA02

ATC

tamsulosin; oral

4.6

307.7

10299

33887

KDE20

NOMESCO Finland

Removal of foreign body from urethra

10.6

307.7

414

328

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.9

307.7

3684

12039

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

17.4

307.7

308

148

Z3231

NOMESCO Finland

Registered nurse

2.0

307.7

5267

25562

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

16.0

307.7

424

223

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

4485

20136

J01CA08

ATC

pivmecillinam; oral

2.1

307.7

4866

22501

U05

ICPC

Urination problems other

8.9

307.7

2509

2636

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

5.7

307.7

5045

9554

U29

ICPC

Urinary symptom/complaint other

8.3

307.7

1134

1190

U08

ICPC

Urinary retention

35.4

307.7

2173

573

TKD00

NOMESCO Finland

Dilatation of urethra

16.2

307.7

425

220

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

38.9

307.7

688

151

R35

ICD-10 Finland

Polyuria

7.8

307.7

1796

2086

U06

ICPC

Haematuria

8.9

307.7

895

862

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

77.1

307.7

1591

186

J01MA12

ATC

levofloxacin; systemic

2.7

307.7

4740

17406

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

43.7

307.7

730

143

R31

ICD-10 Finland

Unspecified haematuria

33.9

307.7

4893

1620

XKD06

NOMESCO Finland

Physiologic investigation of micturition

13.5

307.7

1410

927

KED33

NOMESCO Finland

Transurethral incision of prostate

15.2

307.7

865

490

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

307.7

4649

18186

XKD03

NOMESCO Finland

Urethral pressure profilometry

7.3

307.7

570

656

N35.9

ICD-10 Finland

Urethral stricture, unspecified

10.1

307.7

610

510

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

7.2

307.7

2660

3466

SPAT1167

SPAT

Insertion of urinary catheter

11.8

307.7

2128

1658

A28

ICPC

Limited function/disability NOS

2.5

307.7

4227

16412

TKC20

NOMESCO Finland

Catheterisation of bladder

9.1

307.7

3925

4417

N40

ICD-10 Finland

Hyperplasia of prostate

4.5

307.7

9566

30442

G04CA01

ATC

alfuzosin; oral

2.6

307.7

4082

14913

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.0

305.8

1524

4401

KED76

NOMESCO Finland

TUVP

11.8

303.8

346

244

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

303.4

5838

30047

KDV10

NOMESCO Finland

Internal urethrotomy

7.1

301.1

498

588

G04BD08

ATC

solifenacin; oral

3.2

296.8

1343

3661

J01MA06

ATC

norfloxacin; oral

2.4

293.1

2317

8475

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

290.0

2357

8728

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

288.5

8700

51148

N02BE01

ATC

paracetamol; systemic, rectal

2.2

288.4

15114

105730

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

288.4

2377

8856

N03AX16

ATC

[U] pregabalin

2.0

286.7

4112

19099

U02

ICPC

Urinary frequency/urgency

2.4

283.7

2216

8054

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

283.6

3191

13536

N30

ICD-10 Finland

Cystitis

3.2

277.2

1239

3349

U01

ICPC

Dysuria/painful urination

3.2

276.0

1204

3206

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2.2

274.0

2871

11826

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.8

273.1

1508

4603

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

9.0

271.8

371

344

KC1AT

NOMESCO Finland

Puncture of urinary bladder with ultrasound guidance

50.8

271.1

184

ZXD05

NOMESCO Finland

Urgent procedure

1.8

270.6

5654

29636

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

269.6

4224

20169

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

268.7

6331

34399

U71

ICPC

Cystitis/urinary infection other

3.4

268.0

1055

2631

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

5.0

264.4

627

1064

7882A

ICD-9 Finland

Symptoms involving urinary system, Retention of urine

+∞

263.0

272

J01DB01

ATC

cefalexin; oral

1.9

262.2

13737

93820

N05AH04

ATC

quetiapine; oral

2.1

260.3

2886

12134

SPAT1171

SPAT

Bladder puncture

118.9

258.8

158

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

249.1

4567

22870

N06AX11

ATC

mirtazapine; oral

1.8

248.6

5429

28687

U04

ICPC

Incontinence urine

3.1

246.2

1131

3103

SPAT1254

SPAT

Administration of medicine

2.1

245.0

2995

13043

TKC20, ,

SPAT

20.2

244.5

214

SPAT1229

SPAT

Assessment of need for aid

2.5

242.9

1716

5927

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

238.6

5648

30481

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

236.8

5678

30742

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

233.6

2870

12501

ZXE00

NOMESCO Finland

One hour or less

1.7

232.9

6505

36723

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.0

230.5

541

909

SPAT1216

SPAT

Assessment of functional ability

2.0

227.6

3137

14228

N03AX12

ATC

[U] gabapentin; oral

2.0

224.4

2799

12244

116

Kela drug reimbursment

Prostate cancer

2.3

223.3

1920

7241

UKD02

NOMESCO Finland

Urethroscopy

13.9

223.1

232

139

A04

ICPC

Weakness/tiredness general

2.1

221.6

2586

11031

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.4

220.5

884

2226

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

7.2

217.2

355

413

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

217.0

3512

16790

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

215.6

2526

10783

M03BX01

ATC

baclofen; systemic

5.3

215.0

473

749

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

213.8

3078

14143

K59.0

ICD-10 Finland

Constipation

2.7

212.5

1242

3892

R50.9

ICD-10 Finland

Fever, unspecified

2.0

207.8

2787

12482

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

204.1

4232

21790

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

72.2

203.6

131

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.0

201.9

1008

2896

SPAT1263

SPAT

Sampling

1.6

201.9

6857

40344

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

201.8

5173

28271

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.9

201.6

478

810

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

201.1

5266

28940

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

201.0

3570

17529

N06AX21

ATC

duloxetine; oral

2.3

200.0

1734

6548

UJF32

NOMESCO Finland

Coloscopy

1.7

198.2

4671

24918

N02AX02

ATC

tramadol; systemic, rectal

1.6

198.1

7482

45140

N05BA04

ATC

oxazepam; oral

1.8

197.4

4197

21737

U99

ICPC

Urinary disease other

8.6

197.1

277

267

KCV04

NOMESCO Finland

Distension of bladder with fluid

17.0

196.9

185

SPAT1301

SPAT

No procedures

1.7

193.7

5454

30496

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

4.7

190.5

479

854

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

189.5

3018

14282

TKC50

NOMESCO Finland

Training of urinary bladder

50.0

186.5

127

A02BC02

ATC

pantoprazole; systemic

1.6

185.5

11171

74899

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

183.4

1065

3320

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

19.9

183.0

161

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

182.4

1751

6888

N05CF01

ATC

zopiclone; oral

1.6

179.5

5630

32223

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

12.3

178.0

198

134

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

177.9

704

1755

N30.2

ICD-10 Finland

Other chronic cystitis

8.9

174.2

239

223

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.7

171.6

588

1330

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

170.8

4166

22280

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

170.5

2847

13633

B01AB05

ATC

enoxaparin; parenteral

1.6

169.9

5345

30522

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

5.4

169.6

366

569

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

4.8

166.6

409

714

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

166.6

1836

7612

R06.0

ICD-10 Finland

Dyspnoea

1.7

166.3

4619

25535

C07AB07

ATC

bisoprolol; oral

1.5

165.3

9079

58863

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.8

164.7

547

1210

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

164.4

6223

37080

WX002

NOMESCO Finland

Sedation and analgesia

1.8

164.2

3317

16805

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

163.4

1175

4067

N07AB01

ATC

carbachol; systemic

8.9

162.4

222

206

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

6.7

161.7

279

345

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

161.0

1629

6529

KCW96

NOMESCO Finland

Other operations on bladder

8.8

160.7

222

209

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

159.8

1476

5702

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

158.6

1536

6048

R11

ICD-10 Finland

Nausea and vomiting

2.2

157.6

1429

5477

N05AX08

ATC

risperidone; systemic

2.1

157.4

1644

6670

KH1AD

NOMESCO Finland

CT of urinary organs

3.2

157.0

682

1801

N05AH03

ATC

olanzapine; systemic

2.6

156.8

977

3153

G04BD07

ATC

tolterodine; oral

2.8

156.7

865

2621

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

156.3

1178

4165

D12

ICPC

Constipation

3.0

154.6

768

2195

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

5.4

154.5

331

511

N03AE01

ATC

clonazepam; systemic

2.6

153.2

1018

3391

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

10.2

152.7

190

154

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

152.3

10933

74528

N05AA02

ATC

levomepromazine; systemic

2.8

151.6

820

2457

R4110

NOMESCO Finland

Physiotherapy

1.6

150.8

4450

24871

N06AX16

ATC

venlafaxine; oral

2.0

150.7

1795

7645

R60.0

ICD-10 Finland

Localized oedema

1.9

149.3

2183

9982

WX402

NOMESCO Finland

General anaesthesia

1.7

148.3

3126

15977

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

16.3

148.2

142

SPAT1125

SPAT

Stoma care and guidance

4.1

148.0

442

904

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

4.6

145.9

374

677

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

8.5

145.8

206

200

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

13.1

144.7

155

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.8

144.2

776

2318

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.8

144.1

478

1056

G04BD11

ATC

fesoterodine; oral

3.5

143.7

528

1252

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

143.5

2651

13029

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

20.2

143.2

125

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

143.1

3044

15580

J01XE01

ATC

nitrofurantoin; oral

4.9

143.1

341

580

L02AE02

ATC

leuprorelin; implant, parenteral

2.2

142.6

1309

5035

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

142.1

1850

8124

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

4.1

142.0

419

849

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

6.1

141.8

266

360

L02BB03

ATC

bicalutamide; oral

2.7

140.8

848

2687

R42

ICD-10 Finland

Dizziness and giddiness

1.6

140.4

3805

20757

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

140.1

2281

10781

78610

ICD-8 Finland

Symptoms referable to genito-urinary system, Retention of urine

+∞

139.1

144

U70

ICPC

Pyelonephritis/pyelitis

5.0

138.9

326

547

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

21.7

138.7

118

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

138.1

2901

14782

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

10.1

137.2

172

141

Z2221

NOMESCO Finland

Medical doctor

1.6

137.0

4210

23668

R34

ICD-10 Finland

Anuria and oliguria

31.5

136.3

103

A29

ICPC

General symptom/complaint other

1.9

136.2

2148

10045

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

136.1

2419

11737

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.5

135.4

495

1170

M48.0

ICD-10 Finland

Spinal stenosis

1.8

134.3

2289

10963

J01MA01

ATC

ofloxacin; systemic

2.0

134.2

1627

6959

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

134.0

1284

5023

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

15.9

133.2

129

A01

ICPC

Pain general/multiple sites

2.1

132.9

1438

5898

B02AA02

ATC

tranexamic acid; systemic

2.0

132.7

1652

7133

ZX136

NOMESCO Finland

Intravesicalis

7.7

131.2

200

214

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

130.4

891

3004

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.5

130.3

491

1184

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

130.2

1302

5178

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

129.7

2839

14605

S97

ICPC

Chronic ulcer skin

2.2

128.4

1250

4918

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

128.1

937

3261

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

127.4

1556

6668

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

5.5

127.0

267

405

N03AX09

ATC

lamotrigine; oral

2.9

126.5

632

1810

SPAT1234

SPAT

Support of social functional capacity

2.3

126.1

1028

3755

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

126.0

1572

6787

SPAT1172

SPAT

Guidance concerning hydration

3.2

125.4

546

1443

N05BA01

ATC

diazepam; systemic, rectal

1.8

125.2

2125

10149

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

124.4

831

2770

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

123.5

1130

4333

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.0

123.5

1561

6769

JN4AD

NOMESCO Finland

Body CT examination

1.9

122.8

1916

8910

J01XX05

ATC

methenamine; oral

6.3

121.7

221

289

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

121.5

4440

25856

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.6

120.5

186

202

Z3226

NOMESCO Finland

Physiotherapist

1.7

120.0

2869

15081

N05CD07

ATC

temazepam; oral

1.8

119.9

2297

11361

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

119.5

6001

37335

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

119.5

2144

10403

KGH10

NOMESCO Finland

Operation for phimosis

2.8

119.1

629

1858

N06AA09

ATC

amitriptyline; systemic

2.0

118.2

1507

6549

C08CA01

ATC

amlodipine; oral

1.5

118.0

6768

43189

Z51.5

ICD-10 Finland

Palliative care

1.9

117.3

1629

7289

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

117.1

2264

11222

M54.5

ICD-10 Finland

Low back pain

1.5

116.7

4852

29006

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

116.6

1314

5463

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

116.3

1912

9030

A41.8

ICD-10 Finland

Other specified sepsis

3.3

115.8

465

1168

G83.4

ICD-10 Finland

Cauda equina syndrome

10.2

115.6

144

117

E86

ICD-10 Finland

Volume depletion

2.9

115.6

590

1710

SPAT1255

SPAT

Intravenous administration of medicine

2.1

115.4

1285

5318

N39.3

ICD-10 Finland

Stress incontinence

2.5

115.0

815

2793

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

114.8

1697

7749

R30.1

ICD-10 Finland

Vesical tenesmus

4.2

114.1

327

648

N18

ICPC

Paralysis/weakness

3.3

113.9

460

1160

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

113.7

2857

15190

R03BB04

ATC

tiotropium bromide; inhalant

1.8

113.2

2115

10374

SPAT1260

SPAT

Consultation of another employee

1.6

112.4

2814

14943

R15

ICD-10 Finland

Faecal incontinence

3.3

112.1

449

1126

Z71.8

ICD-10 Finland

Other specified counselling

1.5

111.8

4155

24212

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

111.0

4788

28785

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

110.8

2055

10054

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

110.4

4730

28392

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

110.1

4728

28388

N02BF02

ATC

pregabalin; oral

2.4

109.6

861

3091

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

108.8

7416

48647

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

108.8

963

3639

P20

ICPC

Memory disturbance

1.7

108.6

2588

13558

N45.0

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis with abscess

7.8

107.8

164

175

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

9.8

107.6

137

115

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

106.4

931

3500

I50.0

ICD-10 Finland

Congestive heart failure

1.8

105.9

1757

8307

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

32.6

105.5

N06AB04

ATC

citalopram; systemic

1.6

105.4

2998

16404

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

105.2

1030

4053

R5110, ,

SPAT

2.1

105.2

1098

4430

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

105.0

1128

4601

R30.9

ICD-10 Finland

Painful micturition, unspecified

8.2

104.7

152

153

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

104.1

1219

5133

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

103.3

956

3677

N35.8

ICD-10 Finland

Other urethral stricture

8.9

103.1

141

131

Y77

ICPC

Malignant neoplasm prostate

2.3

103.1

852

3126

S18

ICPC

Laceration/cut

1.4

102.8

7271

47849

R39.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the urinary system

6.5

102.4

181

230

G82.2

ICD-10 Finland

Paraplegia, unspecified

7.9

102.2

153

160

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

102.1

10230

71517

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

101.2

2343

12163

N05AF03

ATC

chlorprothixene; systemic

3.1

100.7

441

1169

N30.8

ICD-10 Finland

Other cystitis

6.4

100.7

182

237

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

100.5

1368

6067

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

100.3

5237

32561

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

100.2

4536

27427

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

100.1

1110

4579

163

Kela drug reimbursment

Abiraterone and enzalutamide

3.8

100.0

332

734

A10AB05

ATC

insulin aspart; parenteral

1.9

99.9

1383

6167

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

99.8

1345

5944

WX892

NOMESCO Finland

Monitored bed care

1.9

99.6

1389

6209

KCJ00

NOMESCO Finland

Cystostomy

134.5

99.6

114

Z43.6

ICD-10 Finland

Attention to other artificial openings of urinary tract

35.4

99.5

SPAT1053

SPAT

Memory test

1.6

99.4

2863

15688

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.9

99.0

1346

5966

M79.6

ICD-10 Finland

Pain in limb

1.4

99.0

5708

36133

R52.2

ICD-10 Finland

Other chronic pain

2.7

98.8

568

1754

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.9

98.5

510

1489

A10AE04

ATC

insulin glargine; parenteral

1.8

97.8

1760

8516

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

97.5

2829

15522

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

97.4

3184

17956

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

97.4

4433

26807

N86

ICPC

Multiple sclerosis

8.4

97.1

138

135

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.3

97.0

811

2989

JN4BD

NOMESCO Finland

Extensive body CT

1.7

97.0

1874

9255

G35

ICD-10 Finland

Multiple sclerosis

4.6

96.9

246

442

G04BD09

ATC

trospium; oral

3.3

96.7

386

966

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

95.9

5038

31299

N05AX12

ATC

aripiprazole; systemic

3.0

95.8

449

1239

R55

ICD-10 Finland

Syncope and collapse

1.7

95.7

2039

10342

N03AG01

ATC

valproic acid; systemic, rectal

2.2

95.2

898

3479

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.2

95.1

274

545

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.4

94.6

116

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

10.5

94.6

115

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.9

94.6

490

1431

B01AB10

ATC

tinzaparin; parenteral

1.8

93.5

1518

7117

B01AA03

ATC

warfarin; systemic

1.5

93.3

4078

24425

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

92.6

567

1808

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

92.6

1405

6450

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

92.6

5808

37218

A46

ICD-10 Finland

Erysipelas

1.6

92.5

2635

14376

ZX120

NOMESCO Finland

Intravenous

1.8

92.3

1522

7169

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

92.2

1012

4157

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

91.3

1704

8324

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

90.3

412

1119

S06.0

ICD-10 Finland

Concussion

1.8

90.3

1599

7692

N19

ICD-10 Finland

Unspecified kidney failure

2.3

90.3

774

2882

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

90.0

784

2939

WZC30

NOMESCO Finland

Teaching

1.6

89.9

2456

13258

N81.1

ICD-10 Finland

Cystocele

2.4

89.8

660

2297

N41.0

ICD-10 Finland

Acute prostatitis

2.9

89.8

458

1326

R51.80

ICD-10 Finland

Headache

1.7

89.7

1834

9189

OAB50, ,

SPAT

2.1

89.5

950

3852

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

89.2

473

1399

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

89.1

808

3080

Z2446

NOMESCO Finland

Social worker

2.1

88.2

959

3924

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

87.8

799

3049

U53

ICPC

Urological, Instrument/catheter/intubate/dilate

19.8

87.5

R02

ICPC

Shortness of breath/dyspnoea

1.7

87.0

2034

10555

109

Kela drug reimbursment

Multiple sclerosis

5.7

86.8

174

252

N02BF01

ATC

gabapentin; oral

1.9

86.7

1145

5018

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

86.5

1263

5723

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.8

86.5

280

608

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

86.4

6505

42870

L17

ICPC

Foot/toe symptom/complaint

1.5

86.3

4087

24801

KA3EB

NOMESCO Finland

Antegrade pyelography

6.7

85.4

146

179

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

4.2

85.3

240

469

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

84.8

509

1607

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

84.2

1124

4944

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

83.7

6473

42782

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

83.4

2007

10487

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.3

82.9

229

441

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

12.2

82.9

H02AB06

ATC

prednisolone; systemic

1.4

82.8

7485

50702

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

82.7

632

2238

E0000UV, ,

ATC

1.4

82.0

5796

37706

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

82.0

1594

7867

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

81.9

4127

25299

K92.1

ICD-10 Finland

Melaena

1.9

81.8

1068

4661

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

81.2

554

1862

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

81.2

1774

9037

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

6.1

81.0

152

206

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

80.8

2042

10794

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

80.8

2210

11910

W19

ICD-10 Finland

Unspecified fall

1.7

80.8

1579

7802

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

5.0

80.2

184

303

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

79.5

1042

4552

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

78.8

1348

6408

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

78.8

2114

11336

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

78.6

883

3653

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

78.5

457

1420

ZXA05

NOMESCO Finland

Left side

1.4

78.4

3888

23732

N06AB10

ATC

escitalopram; oral

1.6

78.3

2304

12625

J01FF01

ATC

clindamycin; systemic

1.4

78.2

4003

24574

J01CA04

ATC

amoxicillin; systemic

1.4

77.9

12149

89193

C10AA01

ATC

simvastatin; oral

1.3

76.8

7736

53065

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

6.0

76.3

146

202

N07AA03

ATC

distigmine; systemic

9.1

76.2

102

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

75.9

827

3383

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

75.9

643

2381

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

75.8

722

2805

TKC10, ,

SPAT

141.8

75.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

75.5

1215

5669

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

75.3

2646

15066

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

75.3

2230

12227

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.6

75.3

270

630

SPAT1211

SPAT

Application of soft bandage

1.8

74.6

1349

6515

L02BB04

ATC

enzalutamide; oral

3.4

74.5

289

710

UKB02

NOMESCO Finland

Retrograde ureteroscopy

4.0

74.4

224

461

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

74.2

910

3884

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.2

74.2

211

416

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

74.1

2865

16637

R13

ICD-10 Finland

Dysphagia

1.8

73.3

1109

5075

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

73.3

1234

5835

ZXA00

NOMESCO Finland

Right side

1.4

73.1

4118

25668

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

73.1

425

1320

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

73.0

864

3642

L02BX03

ATC

abiraterone; oral

3.8

72.9

234

505

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

72.1

884

3772

C09AA05

ATC

ramipril; oral

1.4

71.8

4587

29194

352

Kela drug reimbursment

Abiraterone and enzalutamide

3.7

71.7

240

534

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.9

71.7

139

195

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

71.6

1184

5567

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

71.4

736

2947

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

71.4

1738

9087

G04AA01, ,

ATC

5.2

71.3

159

255

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

71.3

2246

12476

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

71.0

870

3712

1530

FHL

Urethrocystoscopy

2.7

70.4

401

1232

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.6

70.4

246

564

A99

ICPC

Disease/condition unspecnature/site

1.7

70.1

1382

6833

L02BX02

ATC

degarelix; parenteral

3.0

69.4

323

888

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

69.2

3221

19363

ZXA10

NOMESCO Finland

Bilateral

1.5

69.2

2804

16412

N32.9

ICD-10 Finland

Bladder disorder, unspecified

7.7

69.1

105

112

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.7

69.1

171

301

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

14.4

68.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

68.8

693

2750

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

68.8

1049

4809

G04AC01, ,

ATC

2.7

68.8

383

1163

N32.3

ICD-10 Finland

Diverticulum of bladder

10.9

68.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

68.1

4801

30999

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

3.5

68.0

253

605

A02BC01

ATC

omeprazole; systemic

1.4

67.7

4244

26876

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

67.6

733

2992

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

67.1

1188

5697

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

5.0

67.0

154

254

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

66.8

3017

18020

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.1

66.8

194

389

R52.9

ICD-10 Finland

Pain, unspecified

1.7

66.5

1290

6348

B01AF02

ATC

apixaban; oral

1.5

66.3

2228

12537

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

66.3

385

1195

T90

ICPC

Diabetes non-insulin dependent

1.4

66.1

4021

25321

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

65.9

2179

12219

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

65.8

4699

30371

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

65.7

480

1665

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

65.6

1080

5068

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

65.5

767

3219

N05AD01

ATC

haloperidol; systemic

2.2

65.3

616

2383

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

64.8

436

1456

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.6

64.5

402

1293

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

64.4

1378

6961

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

64.4

3185

19333

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

64.0

422

1395

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.6

64.0

410

1337

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

63.7

4020

25444

N06AX03

ATC

mianserin; oral

2.0

63.7

716

2961

K59.01

ICD-10 Finland

Constipation outlet obstruction type

4.5

63.6

164

299

M05BX04

ATC

denosumab; parenteral

1.9

63.5

823

3577

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

13.0

63.5

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

63.5

610

2377

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.5

63.3

132

199

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

63.1

1803

9779

G82.1

ICD-10 Finland

Spastic paraplegia

23.8

63.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

63.0

3806

23910

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.6

62.8

217

494

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

62.8

4756

30978

SPAT1127

SPAT

Enema

4.0

62.7

191

397

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

62.7

1398

7137

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

62.7

1037

4872

N05AB03

ATC

perphenazine; systemic, rectal

2.3

62.2

499

1804

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

62.2

2180

12365

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

62.1

408

1347

D01

ICPC

Abdominal pain/cramps general

1.7

62.0

1340

6783

N28

ICPC

Limited function/disability (N)

2.8

61.9

320

934

ZY010

NOMESCO Finland

Hospital outpatient

2.2

61.6

585

2268

S70.0

ICD-10 Finland

Contusion of hip

2.1

61.6

645

2597

N06DX01

ATC

memantine; oral

1.6

61.6

1408

7232

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

61.5

2705

16048

Z50.1

ICD-10 Finland

Other physical therapy

1.9

61.4

785

3396

A08

ICPC

Swelling

1.9

60.8

774

3343

SPAT1310

SPAT

Counselling related to known health issue

1.4

60.7

4535

29441

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

60.7

634

2551

KDH70

NOMESCO Finland

Plastic repair of stricture of urethra

25.2

60.6

N32.89

ICD-10 Finland

Other specified disorders of bladder

9.6

60.3

N81.6

ICD-10 Finland

Rectocele

2.1

60.3

577

2244

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

60.3

620

2480

C01DA14

ATC

isosorbide mononitrate; oral

1.4

60.3

3306

20408

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.9

60.2

292

822

R4120

NOMESCO Finland

Occupational therapy

1.8

60.2

913

4176

S01.0

ICD-10 Finland

Open wound of scalp

1.7

60.1

1342

6851

P01AB01

ATC

metronidazole; oral, rectal

1.3

59.7

5058

33452

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

59.6

620

2490

N48.1

ICD-10 Finland

Balanoposthitis

2.3

59.5

498

1834

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

59.4

639

2599

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

59.3

673

2792

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

59.0

1137

5578

OAB43, ,

SPAT

0.6

59.0

882

12397

SPAT1138

SPAT

Guidance concerning bowel function

3.0

58.8

270

737

SPAT1240

SPAT

Therapeutic discussion

1.8

58.3

1046

5029

K07

ICPC

Swollen ankles/oedema

1.9

58.3

753

3268

Y06

ICPC

Prostate symptom/complaint

2.0

58.3

683

2866

A03

ICPC

Fever

1.5

58.2

1894

10566

A02BC05

ATC

esomeprazole; systemic

1.3

58.1

5660

38151

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

58.0

5641

38016

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.7

57.9

328

1005

N17.8

ICD-10 Finland

Other acute renal failure

3.1

57.9

259

696

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

57.9

476

1740

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

57.6

3247

20119

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

57.2

1046

5056

KED10

NOMESCO Finland

Retropubic prostatectomy

8.4

57.2

Z00.8

ICD-10 Finland

Other general examinations

1.7

57.1

1049

5077

L03

ICPC

Low back symptom/complaint

1.4

57.1

3363

20988

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

56.8

1888

10576

SPAT1252

SPAT

Overall medication plan or its review

1.7

56.2

1146

5708

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

56.2

854

3907

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

56.2

425

1498

N04AA02

ATC

biperiden; systemic

2.8

56.2

294

864

N30.4

ICD-10 Finland

Irradiation cystitis

13.0

56.0

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

55.7

305

918

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

55.5

379

1275

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

55.3

1846

10347

R07.3

ICD-10 Finland

Other chest pain

1.6

54.9

1408

7433

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

54.9

733

3216

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

54.9

1262

6486

A10BA02

ATC

metformin; oral

1.3

54.8

4881

32426

R52.1

ICD-10 Finland

Chronic intractable pain

4.2

54.6

156

309

N03AF01

ATC

carbamazepine; oral, rectal

1.9

54.3

788

3552

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

54.3

552

2198

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.1

54.2

101

136

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.4

54.2

398

1384

E87.6

ICD-10 Finland

Hypokalaemia

2.2

54.0

508

1962

P29

ICPC

Psychological sympt/compl other

2.0

54.0

649

2748

KH1EE

NOMESCO Finland

Urologic ultrasound examination

7.4

53.9

N39.8

ICD-10 Finland

Other specified disorders of urinary system

4.7

53.8

133

234

C03DA01

ATC

spironolactone; oral

1.5

53.8

2071

11947

G04BX08, ,

ATC

3.5

53.8

194

455

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

53.8

561

2256

N41.1

ICD-10 Finland

Chronic prostatitis

2.2

53.7

456

1689

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

53.7

276

803

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

53.4

3551

22567

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

53.3

428

1549

R03AC02

ATC

salbutamol; inhalant

1.3

53.1

7415

52242

A06AH03

ATC

naloxegol; oral

2.9

53.1

261

741

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

53.1

742

3305

A10AC01

ATC

insulin (human); parenteral

1.6

53.0

1270

6592

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

53.0

1299

6781

SPAT1325

SPAT

Vaccination

1.3

52.6

5191

34936

N06AB06

ATC

sertraline; oral

1.6

52.4

1215

6255

SPAT1360

SPAT

Extensive global examination

1.7

52.3

1066

5307

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

52.2

462

1741

N06AB03

ATC

fluoxetine; oral

1.6

52.2

1451

7804

R95

ICPC

Chron obstructive pulmonary disease

2.1

52.1

550

2222

A07AA09

ATC

vancomycin; oral

2.9

52.0

251

705

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

52.0

2107

12273

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

51.8

521

2066

N06AX26

ATC

vortioxetine; oral

1.9

51.7

739

3315

A97

ICPC

No disease

1.4

51.7

2467

14817

N17

ICPC

Vertigo/dizziness

1.5

51.6

1641

9093

D06

ICPC

Abdominal pain localized other

1.7

51.5

999

4907

KCC10

NOMESCO Finland

Cystoprostatectomy

4.7

51.5

126

220

X58

ICD-10 Finland

Exposure to other specified factors

1.5

51.4

1789

10105

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

51.0

715

3187

K08.3

ICD-10 Finland

Retained dental root

1.6

50.8

1169

6006

Y85

ICPC

Benign prostatic hypertrophy

2.3

50.7

398

1426

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

50.7

665

2901

A06AC51

ATC

ispaghula, combinations; oral

1.9

50.6

643

2775

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

50.5

5468

37212

N05AN01

ATC

lithium; oral

2.6

50.3

303

959

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

50.2

5764

39527

G82.5

ICD-10 Finland

Tetraplegia, unspecified

10.2

50.0

I50

ICD-10 Finland

Heart failure

2.0

50.0

601

2544

S37.3

ICD-10 Finland

Injury of urethra

15.5

50.0

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.7

49.6

291

909

207

Kela drug reimbursment

Chronic arrhythmias

1.4

49.5

2857

17716

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

2.4

49.4

352

1208

J01MA14

ATC

moxifloxacin; systemic

1.6

49.3

1349

7224

N05AH02

ATC

clozapine; systemic

3.1

49.2

216

574

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

49.2

1246

6552

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

4.9

49.2

115

193

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

49.1

787

3658

B01AC04

ATC

clopidogrel; oral

1.4

49.0

3084

19390

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

49.0

1301

6919

E000001, ,

ATC

1.4

48.6

2591

15847

205

Kela drug reimbursment

Chronic hypertension

1.3

48.5

5035

34038

A10BB12

ATC

glimepiride; oral

1.6

48.4

1339

7188

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.8

48.4

158

346

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

48.3

825

3908

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.1

48.3

142

288

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

14.4

48.2

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

48.1

632

2757

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

48.0

585

2488

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

47.9

665

2954

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

47.9

532

2189

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

47.9

416

1556

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.9

47.9

233

658

G04BX04, ,

ATC

2.4

47.6

338

1158

N99

ICPC

Neurological disease other

3.1

47.5

211

565

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.4

47.5

340

1169

L03AX13

ATC

glatiramer acetate; parenteral

8.0

47.5

J01DA01

ATC

[U] cefalexin

1.3

47.3

9109

66361

N05BE01

ATC

buspirone; oral

2.2

47.2

398

1471

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.5

46.8

120

218

A10BH05

ATC

linagliptin; oral

1.7

46.8

903

4427

C09AA02

ATC

enalapril; systemic

1.3

46.6

3415

21964

A10BH01

ATC

sitagliptin; oral

1.5

46.5

1565

8769

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

46.5

425

1624

V03AE01

ATC

polystyrene sulfonate; oral

2.7

46.4

254

765

XKX00

NOMESCO Finland

Pelvic floor electromyography

8.0

46.1

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

5.6

46.1

139

ZY000

NOMESCO Finland

Hospital inpatient

3.6

46.0

163

378

N07BC02

ATC

methadone; systemic

6.1

45.9

114

Z00.0

ICD-10 Finland

General medical examination

1.4

45.6

2681

16654

G72.8

ICD-10 Finland

Other specified myopathies

2.5

45.5

308

1032

U76

ICPC

Malignant neoplasm of bladder

7.6

45.5

SPAT1285

SPAT

Provision of consultation response

1.8

45.5

777

3680

L29

ICPC

Musculoskeletal sympt/complt other

1.6

45.3

1075

5561

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

45.3

370

1349

SPAT1312

SPAT

General health counselling

1.3

45.3

4220

28065

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.8

45.2

236

693

N04BC05

ATC

pramipexole; oral

1.6

45.2

1039

5332

K90

ICPC

Stroke/cerebrovascular accident

2.0

45.1

523

2186

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

45.0

849

4136

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.5

45.0

162

380

TAB00

NOMESCO Finland

Lumbar puncture

2.0

44.9

545

2314

P99

ICPC

Psychological disorders other

2.5

44.9

297

984

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

44.9

1575

8899

J01CF05

ATC

flucloxacillin; systemic

1.7

44.8

817

3942

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

44.7

494

2029

H26.4

ICD-10 Finland

After-cataract

1.5

44.7

1542

8683

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.6

44.6

154

351

KCB00

NOMESCO Finland

Biopsy of bladder

6.4

44.6

101

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

44.5

202

548

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

44.5

2277

13814

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

44.3

524

2205

N20.0

ICD-10 Finland

Calculus of kidney

2.4

44.3

334

1176

AA400

NOMESCO Finland

Electroconvulsive therapy

4.4

44.3

117

218

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

44.3

990

5045

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

44.3

1347

7384

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

8.4

44.2

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.3

44.0

367

1350

KC1YT

NOMESCO Finland

Suprapubic catheter placement under ultrasound guidance

72.7

43.8

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

43.8

293

977

N05BA12

ATC

alprazolam; oral

1.6

43.7

1208

6479

P18

ICPC

Medication abuse

4.7

43.7

107

187

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.9

43.6

219

630

F03

ICD-10 Finland

Unspecified dementia

1.7

43.6

840

4116

S29

ICPC

Skin symptom/complaint other

1.4

43.5

2562

15904

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.5

43.5

278

906

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

43.5

1590

9057

-53

ICPC

Instrument/catheter/intubate/dilate

11.9

43.4

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

43.2

691

3209

SPAT1153

SPAT

Removal of sutures

1.3

43.2

4698

31848

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

2.3

43.2

362

1335

N03AF02

ATC

oxcarbazepine; oral

2.1

43.0

455

1840

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

42.9

646

2945

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

42.8

1312

7202

SPAT1251

SPAT

Organisation of medication

1.9

42.8

571

2505

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

42.7

713

3353

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.6

42.7

264

847

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

16.1

42.5

N05AA01

ATC

chlorpromazine; systemic, rectal

3.0

42.5

198

546

WF049

NOMESCO Finland

Radiotherapy of metastasis

1.9

42.4

590

2623

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

42.3

642

2934

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

42.3

301

1033

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

42.3

449

1818

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

42.2

567

2492

G82.4

ICD-10 Finland

Spastic tetraplegia

15.0

42.2

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

42.1

1135

6051

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

3.1

42.1

190

514

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

42.1

1018

5290

SPAT1104

SPAT

Monitoring of emergency patient

1.6

42.1

986

5084

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

9.9

42.0

TJF80

NOMESCO Finland

Ostomy education

3.0

42.0

193

528

T83.1

ICD-10 Finland

Mechanical complication of other urinary devices and implants

16.4

41.9

U14

ICPC

Kidney symptom/complaint

2.6

41.9

255

812

L86

ICPC

Back syndrome with radiating pain

1.7

41.9

747

3582

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

41.8

379

1443

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.3

41.7

113

215

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

41.7

286

965

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

41.6

382

1462

N06AA10

ATC

nortriptyline; systemic

2.6

41.6

258

829

R82.7

ICD-10 Finland

Abnormal findings on microbiological examination of urine

7.4

41.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.2

41.5

387

1491

N05CF02

ATC

zolpidem; oral

1.4

41.4

1992

11944

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

41.3

778

3788

KK1XE

NOMESCO Finland

Other ultrasound examination of retroperitoneal space and genito-urinary tract

11.3

41.3

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

41.2

1286

7084

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

41.2

252

804

ZXD35

NOMESCO Finland

Usual procedure

2.0

41.1

494

2091

R10.0

ICD-10 Finland

Acute abdomen

2.0

41.0

445

1817

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

40.8

804

3963

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

40.7

1481

8422

KCC00

NOMESCO Finland

Cystectomy

19.7

40.7

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

40.6

1125

6037

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

40.6

1784

10523

UJH02

NOMESCO Finland

Anoscopy

1.9

40.5

521

2257

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.1

40.5

181

487

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

40.3

962

4983

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

40.1

289

998

N20.1

ICD-10 Finland

Calculus of ureter

1.8

40.1

594

2695

U72

ICPC

Urethritis

2.6

40.0

235

735

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

40.0

1005

5269

A10AE05

ATC

insulin detemir; parenteral

1.7

39.9

798

3948

KED00

NOMESCO Finland

Transvesical prostatectomy

11.0

39.9

XF404

NOMESCO Finland

Ambulatory ECG

1.5

39.9

1309

7288

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

10.7

39.9

N06AA12

ATC

doxepin; systemic

1.7

39.6

720

3470

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

39.6

742

3607

C07AB02

ATC

metoprolol; systemic

1.3

39.4

3493

23004

KA1FN

NOMESCO Finland

Isotope renography

3.9

39.2

120

251

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

39.2

525

2306

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

39.1

739

3600

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

39.0

247

802

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

39.0

562

2527

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.9

39.0

191

542

M54.3

ICD-10 Finland

Sciatica

1.7

39.0

747

3653

S22.3

ICD-10 Finland

Fracture of rib

1.6

39.0

1069

5721

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

39.0

449

1873

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

39.0

393

1561

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

38.7

271

923

TK800

NOMESCO Finland

Hemodialysis

2.2

38.7

345

1305

P76

ICPC

Depressive disorder

1.8

38.7

564

2545

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.0

38.7

442

1838

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

9.6

38.7

WVA20

NOMESCO Finland

Medicine administration

2.1

38.6

378

1485

SPAT1161

SPAT

Ultrasound examination of urinary bladder

4.0

38.6

115

236

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

38.6

269

915

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

38.5

5380

37473

H02AB07

ATC

prednisone; oral

1.4

38.5

1917

11553

P03

ICPC

Feeling depressed

1.7

38.5

815

4094

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.1

38.4

136

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

38.3

745

3658

L76

ICPC

Fracture: other

2.1

38.3

397

1593

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.5

38.2

137

321

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.6

38.1

113

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

38.1

669

3193

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.4

38.0

273

941

N18.0

ICD-10 Finland

End-stage renal disease

2.7

37.9

208

628

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

37.9

1338

7560

N81.5

ICD-10 Finland

Vaginal enterocele

3.1

37.8

169

455

SPAT1139

SPAT

Nutrition survey

1.9

37.8

471

2020

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

37.7

1041

5577

J02AC01

ATC

fluconazole; systemic

1.3

37.7

3902

26200

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.5

37.7

135

316

R06.4

ICD-10 Finland

Hyperventilation

2.8

37.6

192

558

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

3.0

37.5

175

483

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

37.5

397

1606

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

37.5

182

514

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.7

37.5

206

623

C07AA05

ATC

propranolol; systemic

1.4

37.3

2194

13589

F34.1

ICD-10 Finland

Dysthymia

2.1

37.2

355

1380

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

37.2

648

3085

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

5.8

37.2

104

L03AB07

ATC

interferon beta-1a; parenteral

5.5

37.1

113

K62.3

ICD-10 Finland

Rectal prolapse

3.0

37.0

170

465

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.8

36.9

542

2452

KDV20

NOMESCO Finland

Submucous urethral injection

8.9

36.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

36.9

2356

14784

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

36.8

1158

6387

N35.0

ICD-10 Finland

Post-traumatic urethral stricture

8.4

36.6

R63.1

ICD-10 Finland

Polydipsia

6.9

36.6

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

36.5

392

1594

H81

ICPC

Excessive ear wax

1.3

36.4

2697

17295

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

36.4

277

980

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

36.4

718

3540

N45

ICD-10 Finland

Orchitis and epididymitis

4.1

36.3

104

207

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

36.2

838

4304

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

36.2

3408

22585

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

36.2

307

1138

P72

ICPC

Schizophrenia

2.6

36.2

222

710

WX882

NOMESCO Finland

High dependency care

2.0

36.2

436

1848

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

36.1

318

1198

D11

ICPC

Diarrhoea

1.5

36.1

1193

6649

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

4.9

36.1

144

L14

ICPC

Leg/thigh symptom/complaint

1.6

36.0

1015

5463

N29

ICPC

Neurological sympt/complt other

2.3

36.0

285

1026

G20

ICD-10 Finland

Parkinson disease

1.8

36.0

585

2730

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

36.0

161

434

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

36.0

2442

15460

R4110, ,

SPAT

1.6

35.9

1025

5532

A04AA01

ATC

ondansetron; systemic, rectal

1.6

35.9

988

5289

KED72

NOMESCO Finland

Transurethral microwave therapy of prostate

11.6

35.9

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

35.9

290

1054

WW500

NOMESCO Finland

Blood transfusion

1.8

35.8

596

2800

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.4

35.8

259

896

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

35.8

862

4472

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

35.6

258

893

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

35.5

1351

7744

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

35.5

588

2760

EBA00

NOMESCO Finland

Extraction of tooth

1.3

35.4

4656

32135

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.0

35.4

421

1777

J96.1

ICD-10 Finland

Chronic respiratory failure

2.0

35.2

420

1774

Z2445

NOMESCO Finland

Psychologist

2.0

35.2

387

1588

N02

ICD-10 Finland

Recurrent and persistent haematuria

10.1

35.2

KCE00

NOMESCO Finland

Cystolithotomy

11.2

35.2

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

35.1

211

668

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

35.1

338

1320

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

35.0

972

5214

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

4.6

35.0

161

G44.2

ICD-10 Finland

Tension-type headache

1.5

35.0

1356

7801

S76

ICPC

Skin infection other

1.7

34.9

736

3693

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

34.9

3981

27014

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

5.5

34.9

108

NF3AA

NOMESCO Finland

Femur X-ray examination

2.2

34.8

320

1226

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

34.8

994

5366

AN1

Coronary angiography

1.4

34.7

2034

12581

Z29

ICPC

Social problem NOS

2.3

34.6

270

966

A98

ICPC

Health maint/preventive medicine

1.3

34.6

14808

115834

JAH01

NOMESCO Finland

Laparoscopy

1.9

34.5

473

2093

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.5

34.5

1092

6028

-50

ICPC

Medication/prescr/renewal

1.8

34.5

593

2813

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.8

34.4

176

512

D17

ICPC

Incontinence of bowel

3.0

34.3

155

420

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

34.3

208

662

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

34.3

460

2022

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

34.2

735

3706

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.6

34.1

206

654

N87

ICPC

Parkinsonism

2.3

34.0

268

963

N06AX05

ATC

trazodone; oral

2.3

34.0

277

1010

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

34.0

291

1084

K30

ICD-10 Finland

Functional dyspepsia

1.5

33.9

1229

6975

C08CA02

ATC

felodipine; oral

1.4

33.9

1563

9282

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

33.9

477

2129

N05AC02

ATC

thioridazine; oral

2.4

33.9

251

878

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

33.9

819

4253

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1.8

33.8

529

2440

WX704

NOMESCO Finland

Intubation

1.5

33.8

1040

5706

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

33.8

2765

17963

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

33.7

205

653

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

33.7

222

736

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.7

33.6

188

574

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

33.6

526

2427

A11CC03

ATC

alfacalcidol; systemic

2.0

33.5

363

1481

NHQ40

NOMESCO Finland

Amputation of toe

2.1

33.5

325

1272

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

33.5

445

1949

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

33.5

548

2562

A02BC03

ATC

lansoprazole; oral

1.3

33.4

4021

27433

K56.7

ICD-10 Finland

Ileus, unspecified

2.2

33.3

293

1103

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.8

33.3

511

2343

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

33.3

1584

9458

N34.3

ICD-10 Finland

Urethral syndrome, unspecified

8.2

33.3

A06AX04

ATC

linaclotide; oral

6.2

33.3

L03AB08

ATC

interferon beta-1b; parenteral

9.6

33.2

R5130, ,

SPAT

5.4

33.2

107

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

33.2

566

2678

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

33.2

434

1892

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

33.1

140

365

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.1

33.0

190

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

2.0

33.0

372

1541

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.2

33.0

135

345

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

32.9

114

261

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

32.9

239

829

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

32.9

407

1742

359

Kela drug reimbursment

Mirabegroni

4.3

32.8

170

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

32.8

737

3759

S21

ICPC

Skin texture symptom/complaint

1.4

32.7

1860

11443

K92.0

ICD-10 Finland

Haematemesis

1.9

32.5

414

1788

A07AA02

ATC

nystatin; oral

1.6

32.2

767

3967

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

32.1

5128

36081

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

32.1

359

1483

R81

ICPC

Pneumonia

1.8

32.1

509

2359

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

32.0

894

4800

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

32.0

739

3794

S22

ICPC

Nail symptom/complaint

1.6

31.9

836

4423

N06AA06

ATC

trimipramine; systemic

2.1

31.8

298

1151

D21

ICPC

Swallowing problem

2.4

31.8

236

827

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

31.7

402

1734

N39

ICD-10 Finland

Other disorders of urinary system

3.5

31.7

116

276

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

5.4

31.6

103

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2.0

31.6

375

1581

KBV10

NOMESCO Finland

Removal of stent from ureter

3.3

31.6

127

321

H13

ICPC

Plugged feeling ear

1.3

31.5

2905

19158

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.0

31.4

380

1613

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

31.4

347

1427

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.6

31.4

197

638

-69

ICPC

Other reason for encounter NEC

1.8

31.3

515

2412

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

3.1

31.3

137

365

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.9

31.3

385

1645

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.3

31.2

254

926

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

31.1

1531

9194

A02BA02

ATC

ranitidine; systemic

1.3

31.0

2821

18568

Z08

ICPC

Social welfare problem

2.7

31.0

168

505

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.7

31.0

168

505

A01AB09

ATC

miconazole; local oral

1.5

31.0

1063

5966

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

31.0

684

3473

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.1

30.9

319

1279

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

8.6

30.9

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.2

30.8

127

326

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

30.8

398

1728

A12AA04

ATC

calcium carbonate; oral

2.3

30.8

246

890

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

8.9

30.8

NFQ20

NOMESCO Finland

Amputation of femur

2.6

30.8

183

577

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

30.7

277

1054

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

30.7

2509

16281

WYA20

NOMESCO Finland

Home visit

2.1

30.6

289

1120

Z72.2

ICD-10 Finland

Drug use

4.9

30.6

122

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.1

30.5

136

366

Z93.3

ICD-10 Finland

Colostomy status

3.0

30.5

144

401

C03AA03

ATC

hydrochlorothiazide; oral

1.4

30.5

1388

8220

1523, ,

Kela drug reimbursment

3.0

30.4

140

384

Z91.5

ICD-10 Finland

Personal history of self-harm

6.7

30.4

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

30.4

2117

13426

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

30.4

1176

6759

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

30.3

207

698

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.3

30.3

233

829

N05BA02

ATC

chlordiazepoxide; systemic

2.0

30.3

357

1502

SPAT1097

SPAT

Recording of ECG

1.3

30.2

2165

13787

G30.8

ICD-10 Finland

Other Alzheimer disease

1.9

30.1

418

1858

N43.3

ICD-10 Finland

Hydrocele, unspecified

1.9

30.1

381

1644

N06DA03

ATC

rivastigmine; oral, transdermal

1.6

30.0

720

3730

R19.5

ICD-10 Finland

Other faecal abnormalities

2.5

30.0

190

618

3054, ,

Kela drug reimbursment

3.0

30.0

139

383

F10.24

ICD-10 Finland

Alcohol depence active use

2.5

30.0

202

677

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

30.0

371

1588

B82

ICPC

Anaemia other/unspecified

1.9

30.0

420

1873

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

29.9

2964

19713

K78

ICPC

Atrial fibrillation/flutter

1.4

29.8

1330

7847

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

29.8

1133

6489

Y96.9

ICD-10 Finland

Unspecified type of accident

2.2

29.7

250

925

L75

ICPC

Fracture: femur

2.4

29.7

204

690

R04.0

ICD-10 Finland

Epistaxis

1.5

29.7

1174

6774

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

29.6

481

2244

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.2

29.6

249

921

N03AX11

ATC

topiramate; oral

2.4

29.6

219

767

K77

ICPC

Heart failure

1.9

29.5

371

1597

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

29.4

818

4389

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.7

29.4

167

515

SPAT1101

SPAT

Orthostatic test

1.6

29.4

671

3436

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

29.3

1291

7599

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

29.2

159

479

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.4

29.2

109

263

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

2.0

29.1

351

1489

204

Kela drug reimbursment

Leukemia lymphatica

2.1

29.1

301

1209

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

29.0

192

638

M54.1

ICD-10 Finland

Radiculopathy

1.8

29.0

463

2149

A03FA02

ATC

cisapride; oral, rectal

1.5

29.0

1017

5731

G03HA01

ATC

cyproterone; systemic

2.6

28.9

172

543

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

28.9

1518

9213

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.6

28.8

628

3179

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

28.7

817

4404

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

28.7

148

433

D07AB08

ATC

desonide; topical

1.4

28.7

1332

7911

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

28.7

209

726

R96

ICPC

Asthma

1.5

28.7

1110

6376

KFC10

NOMESCO Finland

Bilateral orchiectomy

3.1

28.6

126

337

H25.8

ICD-10 Finland

Other senile cataract

1.4

28.6

1759

10947

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

28.5

778

4156

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

2.1

28.5

296

1191

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

28.4

329

1376

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

28.4

166

519

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.6

28.4

175

562

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.7

28.4

161

496

C05AA08

ATC

fluocortolone; rectal, topical

1.4

28.3

1735

10787

KCF02

NOMESCO Finland

Transluminal endoscopic removal of foreign body from bladder

7.7

28.3

C10AA05

ATC

atorvastatin; oral

1.2

28.3

6643

48402

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

28.3

662

3411

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

28.2

119

310

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

28.2

155

470

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.4

28.1

138

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

28.1

293

1180

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

28.1

513

2476

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

28.1

584

2919

WF002

NOMESCO Finland

Radical radiotherapy

1.5

28.1

933

5201

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.4

28.1

UJD02

NOMESCO Finland

Gastroscopy

1.6

28.0

662

3419

U27

ICPC

Fear of urinary disease other

3.6

28.0

215

S28

ICPC

Limited function/disability (S)

3.1

28.0

123

329

K29

ICPC

Cardiovascular sympt/complt other

1.6

27.9

652

3356

WF004

NOMESCO Finland

Palliative radiotherapy

1.9

27.9

342

1459

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.9

27.9

140

404

KDW96

NOMESCO Finland

Other operations on urethra

4.7

27.9

119

L02AE03

ATC

goserelin; implant

2.3

27.8

212

752

N20.9

ICD-10 Finland

Urinary calculus, unspecified

1.9

27.8

359

1559

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

27.8

752

4008

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

27.8

1345

8046

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

27.8

701

3676

7362

FHL

Urethral dilatation in anesthesia or operating room

12.1

27.8

OAA80, ,

SPAT

0.5

27.8

196

3526

R4120, ,

SPAT

3.1

27.8

118

309

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

27.8

297

1208

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.9

27.7

362

1578

D09

ICPC

Nausea

1.8

27.7

400

1801

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.5

27.7

185

618

H46

ICD-10 Finland

Optic neuritis

3.5

27.7

100

236

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

27.7

1335

7982

D64.8

ICD-10 Finland

Other specified anaemias

2.1

27.7

289

1165

N05AF05

ATC

zuclopenthixol; systemic

2.9

27.6

132

371

R25.2

ICD-10 Finland

Cramp and spasm

2.0

27.6

300

1228

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

5.1

27.5

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.9

27.3

105

KCH00

NOMESCO Finland

Suture of bladder

5.8

27.3

F45.0

ICD-10 Finland

Somatization disorder

4.5

27.3

128

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

27.2

3383

23081

P06

ICPC

Sleep disturbance

1.4

27.2

1224

7228

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.2

27.2

114

296

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

27.2

805

4379

G82.0

ICD-10 Finland

Flaccid paraplegia

9.6

27.1

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

27.1

1116

6486

P15

ICPC

Chronic alcohol abuse

1.9

27.1

354

1544

D07AC01

ATC

betamethasone; topical

1.2

27.0

4929

35012

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

27.0

336

1441

K56.0

ICD-10 Finland

Paralytic ileus

2.5

27.0

176

581

F13.09

ICD-10 Finland

Intoxication caused by sedative and hypnotic UNS

10.4

27.0

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

4.9

27.0

106

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.4

27.0

103

252

SPAT1281

SPAT

Other administrative function

1.5

27.0

1004

5723

IGV01

NOMESCO Finland

Psychiatric network contact

3.7

27.0

201

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

26.9

385

1729

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

26.9

201

707

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

26.9

281

1133

C67

ICD-10 Finland

Malignant neoplasm of bladder

5.2

26.9

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.8

26.8

385

1731

Y02

ICPC

Pain in testis/scrotum

2.8

26.8

140

413

A05

ICPC

Feeling ill

1.7

26.8

544

2704

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

26.7

282

1141

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

26.7

707

3750

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

7.3

26.7

R60.1

ICD-10 Finland

Generalized oedema

3.3

26.6

104

259

A11

ICPC

Chest pain NOS

1.4

26.5

1054

6085

JGC01

NOMESCO Finland

Laparoscopic rectopexy

3.8

26.5

181

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

26.5

971

5519

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

26.5

390

1768

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

26.4

581

2947

N21.1

ICD-10 Finland

Calculus in urethra

4.9

26.4

105

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

26.4

374

1675

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.4

26.3

236

T19.1

ICD-10 Finland

Foreign body in bladder

11.1

26.3

N05CD02

ATC

nitrazepam; oral

2.0

26.3

280

1137

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

26.3

1791

11308

LEG12

NOMESCO Finland

Transobturatoric tape

3.2

26.3

106

269

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

4.7

26.3

112

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.4

26.2

180

610

W17

ICD-10 Finland

Other fall from one level to another

1.6

26.1

566

2860

ZXC20

NOMESCO Finland

Use of chemical agents

2.0

26.1

299

1247

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.7

26.0

513

2529

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

5.9

26.0

J46

ICD-10 Finland

Status asthmaticus

1.9

26.0

336

1461

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.2

25.9

234

892

127

Kela drug reimbursment

Transplant complication

2.4

25.9

190

663

L04AA06

ATC

mycophenolic acid; systemic

2.2

25.9

221

824

S06

ICPC

Rash localized

1.6

25.8

695

3701

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

25.7

2370

15590

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.5

25.7

170

566

N81

ICPC

Injury nervous system other

5.0

25.6

P01

ICPC

Feeling anxious/nervous/tense

1.5

25.6

833

4623

Y94.0

ICD-10 Finland

Accident at home

2.1

25.6

264

1060

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.1

25.6

262

1049

A91

ICPC

Abnormal result investigation NOS

1.6

25.5

603

3114

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

25.5

1257

7541

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

25.5

1292

7789

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

25.4

146

453

A27

ICPC

Fear of other disease NOS

1.6

25.4

597

3078

L13

ICPC

Hip symptom/complaint

1.3

25.4

2161

14066

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.4

25.3

185

645

N41.3

ICD-10 Finland

Prostatocystitis

5.1

25.3

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.0

25.3

276

1132

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.1

25.2

147

R03BA05

ATC

fluticasone; inhalant

1.3

25.2

2127

13832

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

25.2

782

4298

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

25.1

2371

15639

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.0

25.1

284

1179

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

25.1

472

2298

KAC20

NOMESCO Finland

Nephroureterectomy

7.5

25.1

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.0

25.1

116

320

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

25.0

842

4704

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

25.0

879

4954

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.1

25.0

S14.0

ICD-10 Finland

Concussion and oedema of cervical spinal cord

5.6

25.0

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

24.9

1265

7625

C66

ICD-10 Finland

Malignant neoplasm of ureter

6.1

24.8

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1.8

24.8

379

1738

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

24.8

6878

50669

S20

ICPC

Corn/callosity

1.9

24.8

300

1276

D18

ICPC

Change in faeces/bowel movements

1.9

24.7

300

1277

X57

ICD-10 Finland

Unspecified privation

1.9

24.7

302

1289

K02.1

ICD-10 Finland

Caries of dentine

1.2

24.6

7221

53437

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

24.6

652

3460

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.6

24.5

112

N06AX12

ATC

bupropion; oral

1.6

24.5

546

2779

XX3XW, ,

NOMESCO Finland

3.2

24.5

101

260

P28

ICPC

Limited function/disability (P)

3.1

24.4

108

290

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.2

24.4

202

744

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.2

24.4

206

765

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

1.8

24.4

392

1826

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

24.3

307

1324

L02AE04

ATC

triptorelin; parenteral

2.1

24.3

232

904

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

24.3

375

1724

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

24.3

1652

10422

KH1DD

NOMESCO Finland

CT urography of urinary organs

5.5

24.3

U77

ICPC

Malignant neopl urinary tract other

4.5

24.3

113

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.6

24.3

670

3589

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.3

24.2

198

725

ZXC14

NOMESCO Finland

Other special laser technic

7.1

24.2

ABD40

NOMESCO Finland

Implantation of spinal injection device

26.2

24.2

NAJ32

NOMESCO Finland

Posterior reduction of fractrue of lumbar spine

4.9

24.1

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.2

24.1

210

790

L12

ICPC

Hand/finger symptom/complaint

1.3

24.0

1770

11293

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

24.0

391

1828

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

24.0

1160

6935

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

8.7

24.0

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

24.0

160

535

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

24.0

1909

12312

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

24.0

330

1465

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

24.0

273

1137

I95.2

ICD-10 Finland

Hypotension due to drugs

2.6

24.0

139

434

M10.9

ICD-10 Finland

Gout, unspecified

1.4

23.9

1192

7163

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

23.9

491

2448

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

23.9

864

4898

N04BB01

ATC

amantadine; oral

2.2

23.9

203

756

K28

ICPC

Limited function/disability (K)

1.8

23.8

350

1587

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

9.4

23.8

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

23.8

5657

41078

RF220, ,

NOMESCO Finland

2.3

23.8

193

705

I20.09

ICD-10 Finland

Unstable angina

1.4

23.7

966

5602

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

23.7

273

1142

S37.2

ICD-10 Finland

Injury of bladder

10.4

23.6

N99.9

ICD-10 Finland

Postprocedural disorder of genitourinary system, unspecified

10.4

23.6

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.7

23.6

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

23.6

1148

6870

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

23.5

272

1140

M79.1

ICD-10 Finland

Myalgia

1.3

23.3

1462

9110

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.0

23.3

256

1052

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

23.3

183

659

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

3.8

23.3

160

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1.6

23.3

608

3216

N05AE04

ATC

ziprasidone; systemic

4.2

23.3

124

B01AB04

ATC

dalteparin; parenteral

1.5

23.3

685

3722

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

23.3

504

2548

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.7

23.2

463

2290

F31

ICD-10 Finland

Bipolar affective disorder

2.8

23.2

121

357

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

23.2

409

1956

H3603, E103,

ICD-10 Finland

2.9

23.2

114

326

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.0

23.1

N03AX14

ATC

levetiracetam; systemic

1.8

23.1

374

1746

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.5

23.0

666

3604

N07BB01

ATC

disulfiram; oral

1.6

23.0

491

2472

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1.9

23.0

303

1326

F44.4

ICD-10 Finland

Dissociative motor disorders

9.9

23.0

P74

ICPC

Anxiety disorder/anxiety state

1.9

23.0

312

1379

KC1GD

NOMESCO Finland

CT cystography of bladder

10.5

23.0

M54.8

ICD-10 Finland

Other dorsalgia

1.7

22.9

460

2280

R06AE07

ATC

cetirizine; oral

1.2

22.9

5083

36655

A07DA03

ATC

loperamide; oral

1.7

22.8

468

2332

C08CA05

ATC

nifedipine; systemic

1.4

22.8

982

5751

C02CA01

ATC

prazosin; oral

1.9

22.8

300

1313

M01AH01

ATC

celecoxib; oral

1.3

22.8

2176

14362

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

22.8

864

4944

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

22.8

444

2184

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

5.8

22.8

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

6.4

22.7

XG466

NOMESCO Finland

Sleep oxymetry

1.7

22.7

419

2030

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

22.7

508

2589

C10AC01

ATC

colestyramine; oral

1.9

22.7

302

1327

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

22.7

210

810

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.5

22.7

151

505

J01AA02

ATC

doxycycline; systemic

1.2

22.6

11505

88817

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

22.6

536

2770

C09BA02

ATC

enalapril and diuretics; systemic

1.4

22.6

1285

7887

X78

ICD-10 Finland

Intentional self-harm by sharp object

4.1

22.6

134

N81.4

ICD-10 Finland

Uterovaginal prolapse, unspecified

3.3

22.6

227

R4180

NOMESCO Finland

Podiatric therapy

2.4

22.5

160

551

KBH20

NOMESCO Finland

Replantation of ureter

6.1

22.5

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

22.5

2533

17048

M04AA01

ATC

allopurinol; systemic

1.3

22.5

2381

15911

L84

ICD-10 Finland

Corns and callosities

1.7

22.4

429

2099

H53.2

ICD-10 Finland

Diplopia

1.7

22.4

413

2000

JG1JB

NOMESCO Finland

Defekography with X-ray

3.6

22.4

176

J96.0

ICD-10 Finland

Acute respiratory failure

2.1

22.4

222

879

M89.0

ICD-10 Finland

Algoneurodystrophy

3.2

22.4

241

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

22.3

1944

12682

KEB00

NOMESCO Finland

Biopsy of prostate

2.0

22.3

256

1070

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

22.2

412

1999

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.5

22.2

687

3773

D07AA02

ATC

hydrocortisone; topical

1.3

22.2

1582

10045

N05AF01

ATC

flupentixol; systemic

2.3

22.2

181

663

J01FA06

ATC

roxithromycin; oral

1.2

22.1

5171

37428

C08CA13

ATC

lercanidipine; oral

1.3

22.1

2002

13121

OAB48, ,

SPAT

0.6

22.1

442

5818

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.4

22.1

155

531

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.6

22.1

573

3027

RS221, ,

NOMESCO Finland

2.3

22.0

176

639

A10AD05

ATC

insulin aspart; parenteral

1.8

22.0

309

1382

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

21.9

176

640

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

21.9

2553

17245

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.3

21.9

211

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.9

21.9

274

1180

SPAT1284

SPAT

Extensive health certificate

1.8

21.8

324

1474

T89

ICPC

Diabetes insulin dependent

1.7

21.8

419

2054

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.3

21.7

173

627

TKC22, ,

SPAT

55.4

21.7

X84

ICD-10 Finland

Intentional self-harm by unspecified means

5.6

21.7

G04BD10

ATC

darifenacin; oral

3.3

21.7

208

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.7

21.7

157

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

21.7

930

5444

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

4.8

21.7

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

21.6

681

3753

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

2.9

21.6

102

285

L05

ICPC

Flank/axilla symptom/complaint

1.5

21.6

700

3882

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7280

39689

1.86

320.23

6.8

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5333

26448

1.94

311.87

5.8

3.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4636

17244

2.64

307.65

5.1

2.6

1.66

1.82

e6/l

0.70

3012

9202

(3030467) Casts [#/volume] in Urine by Automated count

7693

30697

2.87

307.65

5.5

2.8

0.33

0.52

e6/l

12.10

6536

23308

(3026782) Osmolality of Urine

6154

22041

2.98

307.65

4.5

2.6

525.66

564.22

mosm/kgh2o

37.96

5483

18817

(3021601) Nitrite [Presence] in Urine by Test strip

9603

50884

2.21

307.65

8.0

4.4

0.00

estimate

0.80

2184

9477

(3024561) Albumin [Mass/volume] in Serum or Plasma

8991

49349

2.01

307.65

5.8

4.8

33.65

34.83

g/l

61.84

8336

45576

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9381

50849

2.10

307.65

3.3

2.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

13171

73433

2.87

307.65

7.3

3.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

11538

67125

2.19

307.65

6.8

4.8

7.02

6.89

mmol/l

5.73

11077

62959

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4611

19616

2.26

307.65

2.2

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

10060

56478

2.08

307.65

8.7

6.7

1.21

mmol/l

3.60

8481

47623

(3031040) Bacteria [#/volume] in Urine by Automated count

13514

70151

3.49

307.65

9.1

3.8

1296.48

1437.32

e6/l

0.14

316

1119

(3002582) Erythrocytes [#/volume] in Urine

8455

33316

3.08

307.65

5.7

2.8

165.68

64.79

e6/l

5.64

7178

25464

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4897

18835

2.57

307.65

4.8

2.5

1.20

1.09

e6/l

0.39

3259

10728

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13000

84886

1.98

307.65

9.8

7.5

84.20

80.20

u/l

8.38

12328

79608

(3000850) Epithelial cells [#/volume] in Urine

6488

22990

3.08

307.65

4.1

2.3

4.04

4.38

e6/l

1.53

6004

20506

(3026008) Bacteria identified in Urine by Culture

9774

28843

5.00

307.65

5.4

2.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10115

57906

2.02

307.65

7.2

6.2

11.53

12.61

umol/l

13.40

9609

54947

(3022217) INR in Platelet poor plasma by Coagulation assay

10312

57560

2.13

307.65

20.2

17.7

1.33

1.36

inr

2.03

3087

16090

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6612

34655

1.91

307.65

3.2

2.5

69.33

63.72

u/l

0.19

6141

31927

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5875

29756

1.93

307.65

2.5

2.2

3.08

3.04

mg/l

0.44

4998

25183

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9236

51380

2.00

307.65

7.7

6.1

1.20

1.21

mmol/l

4.69

8436

46583

(3035350) Ketones [Presence] in Urine by Test strip

9687

51077

2.23

307.65

6.1

3.4

0.00

estimate

0.42

2371

10076

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1832

5587

2.89

307.65

4.3

2.3

0.25

0.32

e6/l

1.52

1803

5484

(3049717) Cytology report of Urine Cyto stain

2083

2639

7.21

307.65

2.9

—

(3015736) pH of Urine

7958

40960

2.08

307.65

5.3

3.2

5.90

5.80

1.32

317

2080

(3009261) Glucose [Presence] in Urine by Test strip

9690

51577

2.20

307.65

6.1

3.4

0.00

estimate

0.09

2129

9061

(3023368) Bacteria identified in Blood by Culture

7946

33522

2.72

307.65

5.7

4.2

—

(3018095) Leukocytes [#/volume] in Urine

9008

37980

2.93

307.65

6.5

3.2

210.98

86.22

e6/l

15.43

7400

27214

(3044640) Blood type and Crossmatch panel - Blood

6883

34717

2.03

307.65

3.1

2.5

—

(36304419) Bacteria [Presence] in Urine

7351

29442

2.80

307.65

5.5

2.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9871

59707

1.81

303.35

6.3

5.0

5.93

3.56

ug/l

3.31

9005

52589

(3013650) Neutrophils [#/volume] in Blood by Automated count

10078

61691

1.79

293.24

10.5

8.7

4.68

4.30

e9/l

35.10

8807

53539

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3498

15266

2.10

289.41

6.5

5.6

1.05

1.03

mmol/l

2.41

3238

14117

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3162

13556

2.11

272.36

2.1

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5215

26665

1.86

270.18

3.0

2.4

—

(3018418) pH of Serum or Plasma

6154

33150

1.80

268.88

5.2

4.0

7.40

1.18

1324

6380

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3958

18508

1.97

268.29

3.3

0.81

0.82

mmol/l

2.44

3651

17259

(3022948) Iron [Moles/volume] in Serum or Plasma

4010

18846

1.97

267.82

2.8

2.5

11.11

12.81

umol/l

43.91

3668

17462

(3002032) Base excess in Venous blood by calculation

2759

11329

2.18

264.57

5.0

3.7

1.58

1.86

mmol/l

3.32

2314

9514

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2766

11373

2.18

264.33

4.9

3.7

5.82

kpa

0.01

2647

11046

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3145

13605

2.09

263.73

2.1

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1920

6762

2.49

261.80

1.7

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7823

45453

1.74

261.20

5.6

3.8

66.07

86.19

ng/l

0.68

6353

34235

(3020779) Urea [Moles/volume] in Serum or Plasma

2740

11274

2.18

261.12

7.2

6.7

11.63

10.80

mmol/l

6.01

2569

10643

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2154

8020

2.37

260.07

1.8

1.6

—

(3012544) pH of Venous blood

2834

11839

2.15

259.83

4.9

3.7

7.39

0.40

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6414

35256

1.77

259.46

2.7

2.1

240.73

234.34

u/l

0.15

6066

32891

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8112

47768

1.73

256.69

2.3

2.0

90.18

92.88

pmol/l

5.93

4711

25915

(3022096) Basophils/100 leukocytes in Blood

8218

48601

1.73

255.70

6.8

5.9

0.59

0.65

19.66

7644

45084

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3759

17525

1.97

255.35

2.8

2.5

2.19

2.27

g/l

14.10

3439

16147

(3019069) Monocytes/100 leukocytes in Blood

8459

50451

1.72

255.04

7.2

6.1

8.84

8.89

0.69

7877

46907

(3006504) Eosinophils/100 leukocytes in Blood

8418

50159

1.72

254.47

6.8

5.8

2.72

2.87

6.84

7844

46579

(3021960) Folate [Moles/volume] in Serum or Plasma

5276

27520

1.82

253.08

1.8

1.6

18.64

19.78

nmol/l

6.03

4568

23521

(3002030) Lymphocytes/100 leukocytes in Blood

8592

51571

1.72

252.04

7.0

6.0

24.03

26.44

66.43

8009

48070

(40760892) CBC W Ordered Manual Differential panel - Blood

8396

50137

1.71

250.33

7.2

6.2

—

(3018010) Neutrophils/100 leukocytes in Blood

8464

50695

1.71

249.19

6.7

5.7

60.47

58.27

46.13

7895

47237

(3019309) Folate [Moles/volume] in Red Blood Cells

4688

23687

1.85

248.41

1.9

1.8

1161.45

1154.28

nmol/l

0.19

3546

17803

(3007853) Bacteria identified in Skin by Aerobe culture

3009

13101

2.07

246.39

2.1

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8014

47390

1.71

246.24

5.2

4.4

21.75

22.22

2.09

4874

24346

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3568

16523

1.97

246.01

2.9

2.5

20.37

22.75

20.32

3018

13910

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6588

36909

1.74

245.96

3.6

3.1

2206.04

1696.83

ng/l

9.12

5760

31971

(3014576) Chloride [Moles/volume] in Serum or Plasma

3384

15413

1.99

244.49

7.8

7.0

104.33

104.53

mmol/l

1.40

3379

15399

(3013115) Eosinophils [#/volume] in Blood

9048

55378

1.70

243.98

6.9

5.8

0.20

e9/l

0.03

7832

48140

(3019198) Lymphocytes [#/volume] in Blood

8993

55018

1.70

242.17

6.7

5.6

1.75

1.92

e9/l

11.85

7854

48225

(3006315) Basophils [#/volume] in Blood

8825

53765

1.69

240.89

6.6

5.6

0.04

e9/l

5.34

7563

46123

(3001604) Monocytes [#/volume] in Blood

8788

53595

1.69

237.76

6.6

5.6

0.64

0.63

e9/l

3.80

7528

45971

(3029937) Albumin [Presence] in Urine by Test strip

5370

28674

1.77

234.47

6.9

3.7

0.00

estimate

0.03

2046

8836

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7408

43328

1.70

232.81

3.4

2.8

161.28

162.49

ug/l

0.10

6676

39544

(3014111) Lactate [Moles/volume] in Serum or Plasma

2548

10625

2.13

232.59

6.9

6.8

1.38

1.40

mmol/l

0.36

2468

10315

(3015377) Calcium [Moles/volume] in Serum or Plasma

6442

36450

1.71

227.33

3.8

3.3

2.34

2.35

mmol/l

6.35

5599

31632

(3002256) Pathology report gross observation

2997

13426

2.00

224.96

1.4

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

5219

27946

1.76

223.50

5.5

4.0

83.04

84.69

4.56

5105

27276

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

14973

107009

1.98

221.07

28.7

15.2

29.55

27.27

mg/l

13.26

13556

86108

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2010

7817

2.25

217.15

4.5

3.6

5.15

5.14

kpa

0.38

1893

7357

(3009343) pH of Capillary blood

1990

7723

2.26

216.01

4.4

3.6

7.42

0.32

325

965

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3787

18663

1.85

212.18

2.2

2.0

30.50

30.07

4.12

3680

18086

(3000991) Gas panel - Venous blood

2388

10041

2.10

211.86

8.6

8.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1930

7468

2.26

210.70

4.3

3.6

1.89

1.75

mmol/l

0.74

1439

5457

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1856

7075

2.29

209.87

2.0

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

2249

9325

2.12

206.58

4.1

3.1

4.61

4.48

kpa

1.56

2137

9021

(3003396) Base excess in Arterial blood by calculation

3130

14632

1.92

205.75

7.2

0.97

1.06

mmol/l

0.55

2469

11469

(3027945) Reticulocytes/100 erythrocytes in Blood

3129

14744

1.90

200.24

2.4

1.77

1.75

0.48

2714

12961

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3106

14658

1.90

197.57

7.3

7.2

5.07

5.06

kpa

0.32

2957

13908

(3027801) Oxygen [Partial pressure] in Arterial blood

3104

14650

1.90

197.36

7.3

7.2

11.68

12.00

kpa

2.95

2949

13893

(3042936) Bacteria identified in Isolate by Culture

3396

16600

1.84

193.01

2.4

2.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4615

24687

1.72

192.95

5.6

3.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5834

33398

1.65

187.81

3.5

3.1

0.95

0.78

ug/l

11.70

4595

23191

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1493

5491

2.35

182.25

5.3

4.0

23.76

24.03

mmol/l

2.19

1438

5362

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6791

40597

1.61

181.95

2.4

2.1

77.06

77.57

nmol/l

0.69

5937

35751

(3016502) Oxygen saturation in Arterial blood

2797

13235

1.87

174.30

7.6

7.5

95.28

95.36

0.27

2696

12705

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2986

14597

1.82

166.99

3.6

4.2

242.23

247.64

u/l

0.69

2784

13780

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2584

12085

1.88

166.27

5.0

3.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

11540

78903

1.58

166.24

4.7

4.0

16.00

13.18

mm/h

48.67

10569

72206

(3003181) Sodium [Moles/volume] in Urine

692

1785

3.27

165.60

1.5

1.3

57.36

65.04

mmol/l

5.21

547

1445

(3028626) Oxygen [Partial pressure] in Capillary blood

891

2718

2.78

159.43

3.5

3.0

7.96

7.90

kpa

0.52

869

2656

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1711

7045

2.10

157.63

7.0

7.2

24.58

24.70

mmol/l

0.65

1687

6981

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4178

22846

1.66

155.09

5.1

3.9

446.75

574.24

ng/l

0.76

3580

19207

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1961

8552

1.99

154.32

2.3

2.4

376.92

376.66

nmol/l

0.02

1792

7863

(3015235) Bicarbonate [Moles/volume] in Capillary blood

960

3124

2.61

151.42

3.6

3.1

24.64

24.73

mmol/l

0.24

936

3058

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

990

3295

2.55

149.13

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2504

11987

1.83

148.28

8.1

8.0

119.48

121.83

g/l

6.74

2455

11645

(3023520) Reticulocytes [#/volume] in Blood

2362

11110

1.86

147.92

2.5

67.53

68.29

e9/l

0.49

1781

8535

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5685

33815

1.56

147.26

3.7

3.2

32.92

36.55

u/l

2.74

5335

31851

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1359

5285

2.20

144.21

2.0

1.9

2.64

1.99

ug/l

0.86

1165

4666

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3825

20781

1.65

143.97

3.3

3.2

2.46

2.45

mmol/l

3.37

3297

18052

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1582

6575

2.07

141.50

8.4

9.0

24.23

24.24

mmol/l

0.03

1501

6310

(40761536) Microorganisms panel - Urine sediment

1993

8997

1.92

141.12

7.0

3.5

—

(3021589) Normoblasts [#/volume] in Blood

7429

47222

1.50

139.20

14.7

9.8

0.00

e9/l

0.38

6104

38609

(40768804) Tissue Pathology biopsy report

6681

41571

1.51

138.45

2.4

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

15138

112369

1.75

137.36

33.2

18.1

139.06

139.64

mmol/l

112.97

14862

109233

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4025

22371

1.62

137.35

1.8

1.7

1.52

1.43

mg/l

0.58

3214

17365

(3021901) Oxygen saturation in Capillary blood

755

2292

2.78

136.03

3.1

2.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15152

112615

1.74

135.10

33.3

18.2

4.02

4.00

mmol/l

10.53

14857

109304

(40758558) Short blood count panel - Blood

4596

26699

1.56

128.47

8.2

6.8

—

(1616796) Gas panel - Central venous blood

828

2744

2.55

125.46

4.2

3.7

—

(3019150) Specific gravity of Urine by Refractometry

4064

23168

1.57

122.37

6.9

3.8

1.02

kg/l

0.77

684

3507

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1748

7907

1.90

122.03

4.4

3.9

114.94

97.32

ng/l

6.03

1508

6722

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2172

10536

1.79

121.28

2.2

0.20

g/l

3.37

1963

9739

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2035

9698

1.82

120.46

3.0

2.5

67.59

44.68

u/l

0.29

1754

8270

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2425

12193

1.73

119.46

2.9

2.8

9.16

10.30

umol/l

1.42

2087

10668

(40761535) Cells panel - Urine sediment

2010

9569

1.82

119.31

5.1

3.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1681

7567

1.91

118.94

4.3

3.2

124.98

129.08

g/l

10.68

1633

7364

(3020630) Protein [Mass/volume] in Serum or Plasma

2148

10450

1.78

118.58

2.3

2.6

65.74

66.39

g/l

3.25

1935

9455

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1411

5992

2.01

118.15

1.6

1.63

1.54

g/l

2.76

1191

5100

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1105

4312

2.18

115.52

2.3

509.64

637.84

ug/l

0.70

1053

4089

(3013512) EKG study

5537

34135

1.48

114.09

5.3

4.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1125

4453

2.15

113.42

3.1

2.9

0.34

u/ml

0.07

640

2584

(40767503) Oxygen content in Capillary blood by calculation

770

2587

2.51

113.25

2.9

2.5

15.82

16.17

1.45

452

1332

(3022313) Gas panel - Capillary blood

1336

5649

2.02

113.05

4.8

3.8

—

(3022621) pH of Urine by Test strip

1535

6890

1.91

109.13

4.2

2.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1807

8578

1.81

107.62

2.1

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4232

25200

1.50

101.01

1.9

1.7

11601008.50

29388827.32

pmol/l

2.26

3405

20651

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1317

5772

1.94

100.20

3.5

2.7

1.27

1.22

0.90

1310

5739

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1099

4517

2.06

100.11

2.2

1.8

—

(3045414) Leukocytes [Presence] in Urine

1054

4267

2.09

99.94

2.5

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1169

4938

2.01

98.78

2.3

1.9

—

(3000330) Specific gravity of Urine by Test strip

1305

5732

1.94

98.59

5.7

3.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9540

66159

1.40

97.64

4.0

3.1

61.05

55.61

u/l

3.93

8728

60634

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1285

5636

1.94

97.46

3.5

2.7

0.65

0.66

0.29

1279

5609

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1669

7978

1.79

96.60

9.0

8.9

0.63

0.67

3.77

1649

7922

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1670

8007

1.79

95.63

8.9

8.8

1.34

1.38

0.95

1650

7948

(40761511) CBC panel - Blood by Automated count

14676

110323

1.55

95.40

26.2

14.7

—

(3010421) pH of Blood

847

3211

2.22

94.70

4.9

4.1

7.42

0.41

755

2909

(3024928) Oxygen saturation in Venous blood

691

2409

2.41

93.70

3.4

3.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1368

6211

1.88

93.34

4.6

3.3

25.00

25.11

mmol/l

0.48

1314

6039

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1455

6804

1.82

90.27

9.8

—

(3019060) Gas panel - Arterial blood

1786

8873

1.73

90.11

5.1

4.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12988

95620

1.44

89.74

5.0

4.3

2.12

2.19

mu/l

0.20

11640

85840

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1887

9529

1.70

89.69

5.0

3.8

1.22

mmol/l

2.81

1658

8272

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13522

100478

1.45

87.00

26.4

14.5

73.89

76.78

ml/min/173m2

37.70

11860

82770

(3014007) Fractional oxyhemoglobin in Arterial blood

1638

8017

1.75

86.98

9.2

9.0

93.66

93.70

0.08

1632

7982

(3027315) Oxygen [Partial pressure] in Blood

753

2818

2.25

86.75

4.9

4.2

8.39

8.45

kpa

0.42

728

2754

(3013290) Carbon dioxide [Partial pressure] in Blood

750

2807

2.25

86.38

4.9

4.2

4.97

4.98

kpa

0.15

726

2743

(3012501) Base excess in Blood by calculation

749

2806

2.24

86.06

4.9

4.2

2.57

2.61

mmol/l

0.10

499

1900

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10651

76110

1.37

84.84

4.1

3.6

15.03

14.93

pmol/l

3.30

9459

67953

(3023183) Ammonium ion [Moles/volume] in Plasma

711

2627

2.27

84.41

2.6

2.4

31.18

33.80

umol/l

2.15

630

2341

(3006184) Hemoglobin [Mass/volume] in Capillary blood

733

2746

2.24

84.21

2.6

2.2

126.34

128.90

g/l

1.89

616

1968

(3028271) Lactate [Moles/volume] in Capillary blood

574

1931

2.49

83.98

2.2

1.9

1.68

1.77

mmol/l

1.30

559

1883

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8074

55326

1.36

83.10

2.9

2.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2074

10951

1.63

82.59

3.2

3.0

282.85

245.34

ng/l

2.05

1893

9991

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1098

4860

1.91

80.61

5.2

4.0

24.77

24.78

mmol/l

0.03

1010

4435

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

683

2548

2.25

79.21

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

683

2549

2.25

79.13

1.5

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

501

1632

2.56

78.35

6.4

6.2

11.71

11.84

mg/l

0.23

453

1499

(3044889) 12 lead EKG panel

10741

77439

1.35

76.52

4.9

4.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1234

5784

1.81

75.50

5.6

3.9

47.47

47.29

0.09

1219

5711

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2125

11585

1.57

73.45

2.9

2.4

6.69

7.63

ug/l

1.52

1768

10097

(3020682) Albumin/Creatinine [Ratio] in Urine

5848

38677

1.36

72.27

4.2

3.9

14.85

9.07

mg/mmol

11.22

4059

25139

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14879

113648

1.48

71.86

14.0

10.6

25.17

26.56

u/l

8.97

14294

108885

(3009508) Creatinine [Moles/volume] in Urine

5712

37729

1.36

70.80

3.6

3.2

6.92

7.88

mmol/l

55.51

4689

31364

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1602

8270

1.65

69.06

7.8

7.4

24.39

24.48

mmol/l

0.41

1536

7869

(3008295) Osmolality of Serum or Plasma

345

991

2.89

68.62

1.4

1.3

278.37

279.06

mosm/kgh2o

0.17

248

779

(3009542) Hematocrit [Volume Fraction] of Blood

15305

117808

1.50

68.21

40.3

22.6

38.53

40.19

66.21

14213

108713

(3007461) Platelets [#/volume] in Blood

15307

117874

1.50

67.48

40.1

22.5

240.45

238.89

e9/l

1.99

14956

114140

(3052851) Hemolysis interference index of Serum or Plasma

800

3380

1.99

67.05

4.3

3.4

—

(3024731) MCV [Entitic volume]

15309

117928

1.50

66.93

39.9

22.4

91.44

91.52

1.28

15074

115700

(3035941) MCH [Entitic mass]

15307

117910

1.50

66.92

39.9

22.3

30.32

30.50

27.78

15073

115682

(3026361) Erythrocytes [#/volume] in Blood

15309

117932

1.50

66.87

40.1

22.4

4.32

4.48

e12/l

216.55

14907

113688

(3010813) Leukocytes [#/volume] in Blood

15308

117937

1.49

66.65

40.1

22.4

7.30

6.91

e9/l

45.98

14917

113716

(3000963) Hemoglobin [Mass/volume] in Blood

15309

117950

1.49

66.59

40.3

22.6

129.72

135.72

g/l

307.65

15082

115705

(3002385) Erythrocyte distribution width [Ratio]

12202

90484

1.35

66.51

32.7

18.0

15.30

15.28

0.14

12030

88610

(3037121) Protein [Mass/volume] in Urine

870

3801

1.92

66.15

3.2

3.1

0.45

0.32

g/l

1.42

403

1769

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

839

3641

1.94

65.06

1.9

1.7

—

(3003694) ABO and Rh group [Type] in Blood

4454

28614

1.37

64.52

1.4

—

(3012516) Albumin [Mass/volume] in Urine

5523

36715

1.34

63.97

3.6

3.3

392.01

370.89

mg/l

0.14

3976

24305

(40768797) Stomach Pathology biopsy report

2468

14324

1.48

62.99

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

452

1556

2.42

62.91

2.1

1.8

89.17

89.00

0.22

442

1534

(3034860) Kappa light chains.free [Mass/volume] in Serum

909

4112

1.86

62.08

2.6

3.4

62.12

74.51

mg/l

0.40

725

3331

(3017181) Myelocytes/100 leukocytes in Blood

1753

9497

1.57

61.58

4.2

3.9

0.97

0.96

0.06

720

3490

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

907

4112

1.85

61.51

2.6

3.4

61.56

44.27

mg/l

0.63

723

3325

(3005719) IgG [Mass/volume] in Serum or Plasma

1460

7592

1.63

60.82

2.7

2.6

10.66

10.81

g/l

0.54

1310

6922

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

881

3995

1.85

59.67

2.6

3.3

2.49

5.59

ratio

1.04

306

(3021440) Promyelocytes/100 leukocytes in Blood

1657

8971

1.57

58.21

4.2

4.0

0.12

0.11

0.19

628

2989

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1089

5302

1.73

58.09

5.9

5.2

1.69

1.65

0.61

1044

4948

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1002

4788

1.76

57.05

1.9

2.4

7.48

7.42

g/l

0.48

890

4277

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1001

4785

1.76

56.91

1.9

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

998

4776

1.76

56.52

1.9

2.4

3.81

3.78

g/l

0.21

888

4265

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

544

2123

2.14

56.36

1.3

3.95

3.87

mmol/l

0.85

503

1998

(3025159) Blasts/100 leukocytes in Blood

1560

8403

1.57

55.92

4.2

4.0

0.16

0.31

0.80

531

2467

(3014051) Protein [Presence] in Urine by Test strip

636

2644

2.01

55.69

3.4

2.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1068

5237

1.72

55.47

6.0

5.3

0.88

0.03

1023

4887

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

593

2409

2.06

55.31

1.4

1.3

613.83

544.41

mg/l

0.75

561

2288

(3007164) IgA [Mass/volume] in Serum or Plasma

2800

17069

1.41

54.16

1.6

1.5

2.70

2.65

g/l

0.39

1680

10171

(1761482) Bacteria [#/volume] in Urine by Culture

741

3278

1.89

54.14

7.2

3.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

532

2093

2.12

53.99

1.5

1.4

522.70

4260.21

e6/l

1.20

440

1728

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

531

2090

2.12

53.83

1.5

1.4

21.45

21.88

e6/l

0.02

415

1640

(3002179) Metamyelocytes/100 leukocytes in Blood

1581

8624

1.55

53.52

4.0

3.8

0.71

0.67

0.23

612

2968

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

930

4433

1.76

53.34

1.9

2.4

3.01

2.96

g/l

0.79

821

3925

(3016038) Potassium [Moles/volume] in Urine

244

666

3.03

53.14

1.2

32.06

35.90

mmol/l

1.86

204

574

(3019225) pH of Specimen

1980

11394

1.48

51.98

5.2

4.1

—

(3044290) Cell count panel - Cerebral spinal fluid

492

1916

2.14

51.25

1.5

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

858

4052

1.78

50.76

2.2

2.5

0.88

1.14

g/l

1.19

729

3395

(3009445) Proteinase 3 Ab [Units/volume] in Serum

991

4892

1.70

50.13

1.5

16.12

12.11

u/ml

0.35

115

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

930

4515

1.73

49.97

1.9

2.4

10.37

10.41

g/l

0.10

810

3969

(3026493) Urate [Moles/volume] in Serum or Plasma

4696

31381

1.31

49.47

3.0

2.9

3975.17

5676.62

umol/l

2.00

3995

27080

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

170

387

3.63

49.27

3.0

1.7

114.06

113.01

umol/l

0.02

202

(3040151) Glucose [Moles/volume] in Capillary blood

398

1447

2.29

49.02

29.2

6.7

7.53

7.47

mmol/l

0.13

345

1170

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2129

12556

1.45

49.02

3.9

4.1

19.91

28.45

ug/l

0.80

1775

10501

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

342

1163

2.44

48.93

2.6

2.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3031

19057

1.37

48.08

1.3

1.2

1.60

1.91

u/ml

0.82

754

4913

(3028026) IgM [Mass/volume] in Serum or Plasma

1146

5943

1.62

47.89

2.0

1.9

1.37

1.38

g/l

0.04

1027

5364

(3000494) Fungus identified in Specimen by Culture

2098

12390

1.44

47.88

1.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13125

99928

1.30

47.81

7.4

6.2

42.03

40.65

mmol/mol

38.35

11934

91335

(3014271) Vancomycin [Susceptibility]

237

679

2.89

47.47

3.4

3.0

—

(4035726) Immunohistochemistry procedure

1658

9385

1.50

46.95

1.4

—

(3025941) Bacteria identified in Stool by Culture

1039

5301

1.65

46.30

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

127

245

4.28

46.04

2.4

1.6

—

(21494755) Public health laboratory ask at order entry panel

369

6293

0.47

45.29

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

636

2847

1.86

44.76

3.4

3.0

1.94

1.64

mg/l

11.12

567

2567

(3019230) Fractional oxyhemoglobin in Venous blood

482

1964

2.04

44.60

3.5

2.6

62.76

64.29

0.72

477

1953

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

750

3539

1.77

44.44

1.9

2.4

0.02

0.04

g/l

0.87

678

3186

(46235355) HIV 1 and 2 tests - Meaningful Use set

2256

13684

1.40

44.08

1.9

1.7

—

(3000012) Reticulocyte production index

479

1959

2.03

43.88

2.1

2.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

380

1427

2.21

43.37

5.5

4.3

363.01

347.59

umol/l

1.16

326

1205

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

774

3714

1.74

43.27

1.9

2.3

36.50

37.30

g/l

2.80

661

3196

(3028707) Methadone [Presence] in Urine by Screen method

270

873

2.56

42.98

3.8

2.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

163

405

3.32

41.49

19.8

16.5

1436.63

1403.89

nmol/l

0.20

154

390

(3047181) Lactate [Moles/volume] in Blood

813

4008

1.70

41.22

6.6

6.2

1.36

1.34

mmol/l

0.20

725

3542

(3037522) Nuclear Ab [Titer] in Serum

2078

12571

1.40

41.01

1.3

537.72

501.94

titre

0.35

447

2567

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

701

3327

1.76

40.70

1.9

2.4

0.00

g/l

0.25

632

2987

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

660

3086

1.78

40.32

1.5

1.4

18.01

13.20

iu/ml

0.33

(3000570) Elastase.pancreatic [Mass/mass] in Stool

652

3045

1.79

39.99

1.5

1.4

254.27

255.72

ug/g

0.06

385

1845

(3045424) Erythrocytes [Presence] in Urine

397

1570

2.10

39.80

1.7

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

686

3268

1.75

39.32

2.0

2.4

0.00

g/l

-0.00

630

2978

(40760888) Immunoglobulin light chains.free panel - Serum

659

3111

1.77

38.97

2.7

3.4

—

(3008037) Lactate [Moles/volume] in Venous blood

622

2888

1.80

38.90

4.8

3.1

1.60

1.68

mmol/l

1.30

610

2822

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

617

2865

1.79

38.58

1.5

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

154

390

3.26

38.08

14.7

11.7

863.79

835.92

nmol/l

0.24

146

369

(40768800) Prostate Pathology biopsy report

751

3713

1.69

37.65

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

424

1758

2.00

37.44

4.3

3.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1667

9872

1.43

36.90

1.7

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

118

257

3.79

36.53

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

589

2744

1.79

36.43

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

271

951

2.36

36.29

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

514

2305

1.85

35.99

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13509

104379

1.27

35.51

5.3

4.9

6.24

6.08

mmol/l

25.86

11965

93866

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

879

4598

1.60

35.27

2.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1712

10273

1.41

35.09

2.2

179.38

153.05

ug/g

1.68

1331

8095

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

223

735

2.51

34.22

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

219

718

2.52

33.98

1.3

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

581

2752

1.76

33.97

5.0

3.2

8.06

7.71

mmol/l

1.80

571

2695

(3018405) Lactate [Moles/volume] in Arterial blood

891

4719

1.58

33.91

4.4

4.3

1.37

1.41

mmol/l

0.56

866

4628

(3022145) Colonoscopy Study observation

1910

11801

1.37

32.71

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

582

2789

1.74

32.68

1.5

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

387

1637

1.96

32.33

3.3

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1769

10848

1.38

31.69

2.1

1.7

1.63

1.57

2.00

1475

9273

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1106

6232

1.49

31.61

2.6

2.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

526

2475

1.77

31.48

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

736

3792

1.62

31.41

1.5

1.6

149.53

263.67

titre

1.52

150

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1686

10293

1.38

31.01

2.2

2.1

10.20

12.40

nmol/l

18.02

1415

9013

(3023410) Appearance of Cerebral spinal fluid

240

858

2.31

30.89

1.6

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1873

11650

1.36

30.62

1.8

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

626

3124

1.67

30.30

2.4

3.68

3.62

g/l

0.41

599

2973

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

485

2265

1.78

29.79

1.5

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

179

570

2.59

29.54

2.5

2.4

—

(3017732) Neutrophils [#/volume] in Blood

1212

7076

1.44

28.77

3.5

2.9

5.66

5.36

e9/l

0.24

895

5502

(3024666) Lithium [Moles/volume] in Serum or Plasma

139

395

2.90

28.45

15.4

11.9

0.64

mmol/l

0.06

126

359

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

524

2.63

28.40

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

486

6637

0.59

28.32

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

167

525

2.63

28.30

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

167

525

2.63

28.30

1.3

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

241

906

2.20

27.60

2.7

1.8

2.84

1.64

u/field

1.56

107

345

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

174

566

2.54

27.54

2.3

1.7

2.90

2.04

u/field

0.84

119

396

(3016018) Differential panel - Cerebral spinal fluid

254

982

2.14

27.13

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

590

2990

1.64

26.92

1.4

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

470

2251

1.73

26.49

1.2

130.00

98.57

titre

—

(3019977) pH of Arterial blood

201

715

2.32

26.25

2.0

2.6

7.41

7.43

0.94

237

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

315

1348

1.93

25.54

1.5

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

398

1837

1.80

25.48

2.0

1.8

23.48

25.11

ug/l

0.17

386

1798

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

553

2801

1.64

25.30

1.5

0.24

g/l

0.28

506

2637

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

513

2.54

25.15

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

371

1685

1.82

25.05

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

908

5154

1.47

24.95

3.2

3.3

4.21

4.42

pmol/l

7.25

800

4572

(3020191) Ethanol [Moles/volume] in Serum or Plasma

224

856

2.16

24.69

2.3

1.3

1.30

1.29

promille

0.01

177

669

(3036489) Thrombin time

716

3880

1.54

24.60

2.0

21.92

21.86

0.07

650

3456

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

566

2905

1.62

24.56

1.5

1.17

g/l

0.06

520

2746

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

350

1573

1.84

24.45

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

296

1262

1.94

24.28

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

106

283

3.09

24.23

1.9

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

741

4063

1.52

24.11

4.9

4.5

3.94

3.93

mmol/l

0.20

728

4027

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

249

1001

2.06

24.08

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

226

3.35

24.04

1.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

301

1302

1.91

23.67

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

301

1304

1.91

23.57

1.5

1.4

—

(3020891) Body temperature

916

5268

1.45

23.51

5.9

5.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

437

2123

1.71

23.44

1.5

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

559

2902

1.60

23.17

1.6

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

324

1447

1.85

23.12

2.2

2.4

1.09

1.30

g/24h

0.88

152

719

(3004809) Band form neutrophils/100 leukocytes in Blood

414

1991

1.72

23.04

3.4

1.52

1.56

0.08

371

1734

(3025468) Yersinia sp identified in Specimen by Organism specific culture

298

1298

1.90

22.97

1.5

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

355

1635

1.80

22.93

2.6

3487.60

6381.29

u/ml

0.22

118

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

305

1340

1.88

22.90

1.5

1.4

—

(3023419) Bacteria identified in Sputum by Culture

403

1937

1.72

22.49

2.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

396

2.66

22.49

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

298

1309

1.88

22.40

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

299

1315

1.88

22.39

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

763

4275

1.49

22.38

3.1

3.4

971.59

2213.80

u/ml

0.77

669

3688

(3051651) Icteric interference index of Serum or Plasma

180

657

2.26

22.23

4.4

4.0

—

(3039000) Anion gap in Blood

550

2881

1.58

21.96

7.8

7.1

11.45

11.33

mmol/l

0.33

511

2579

(3018572) Chloride [Moles/volume] in Blood

550

2882

1.58

21.93

7.8

7.1

104.83

105.05

mmol/l

0.48

511

2580

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

205

794

2.13

21.90

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

332

1523

1.80

21.76

3.4

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

420

2066

1.68

21.55

1.6

1.5

31.67

32.55

g/l

0.67

358

1871

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

198

764

2.14

21.37

1.4

1.2

2.18

2.21

mmol/l

0.09

180

714

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1465

9258

1.33

21.20

3.4

2.7

57.57

62.90

ml/min/173m2

5.64

679

3725

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

431

2154

1.66

20.84

5.8

5.3

803.06

1297.82

iu/ml

0.27

328

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

151

526

2.37

20.78

1.7

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

510

2660

1.59

20.76

3.1

3.0

0.81

nmol/l

0.07

391

2012

(3011288) Drugs identified in Urine by Screen method

293

1314

1.84

20.68

4.2

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

134

443

2.49

20.64

1.6

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

168

620

2.24

20.26

1.3

1.1

56.19

44.75

mg/l

0.42

142

512

(44816559) Phosphatidylethanol [Mass/volume] in Blood

351

1676

1.73

20.10

1.5

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

574

3103

1.54

19.98

2.1

88.58

88.69

0.04

553

2993

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

425

2144

1.64

19.83

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

292

1327

1.82

19.78

3.5

3.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

273

1218

1.85

19.62

1.4

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

305

4265

0.58

19.48

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

154

564

2.25

18.95

1.1

—

(3016879) Cocaine [Presence] in Urine

371

1831

1.68

18.86

3.3

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

202

826

2.02

18.77

1.7

1.3

—

(3004775) Volume in Urine collected for unspecified duration

243

1063

1.89

18.59

2.2

700.19

679.73

0.29

160

681

(3012441) Differential panel - Pleural fluid

329

1585

1.72

18.29

1.6

1.5

—

(3017569) Oxygen content in Arterial blood

156

584

2.20

18.23

1.9

2.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

743

4312

1.43

18.18

1.5

1.8

37.81

38.24

u/l

0.19

641

3731

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

584

3241

1.49

18.00

2.4

2.3

161.54

115.59

ug/min

1.30

361

1891

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.39

17.90

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

518

2807

1.53

17.87

2.4

204.60

199.03

0.71

492

2676

(3042631) Mycobacterium sp identified in Specimen

375

1883

1.65

17.86

2.6

2.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1045

6441

1.35

17.85

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

160

611

2.16

17.82

1.9

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

919

5560

1.38

17.66

1.9

1.8

—

(3004451) EKG impression Narrative

162

624

2.14

17.66

1.4

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

128

447

2.36

17.60

1.2

54.33

63.30

0.39

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

375

1891

1.64

17.58

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

375

1891

1.64

17.58

1.5

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

155

589

2.17

17.48

1.1

381.53

303.20

mg/l

0.77

138

509

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

429

2242

1.58

17.38

1.9

1.6

0.87

0.81

nmol/l

0.73

349

1865

(3051611) Lipemic interference index of Serum or Plasma

262

1201

1.80

17.32

4.2

3.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

516

2819

1.52

17.16

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

378

1926

1.62

17.02

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

1731

1.65

16.75

1.4

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

515

2832

1.51

16.61

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

381

1964

1.60

16.38

3.3

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

484

2636

1.52

16.35

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

437

2.32

16.31

1.1

1.08

u/l

0.01

213

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

290

2.64

16.23

2.3

2.4

137.36

142.96

nmol/l

0.21

257

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

508

2801

1.50

16.19

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

361

1843

1.62

16.15

1.6

1.5

5322.18

2841.25

e6/l

0.59

254

1363

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

188

792

1.96

16.15

1.2

—

(3011412) CD3 cells [#/volume] in Blood

218

967

1.86

16.05

2.2

2.3

1.16

1.07

e9/l

0.85

191

891

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

232

1051

1.82

15.98

1.2

66.29

69.15

u/l

0.14

211

941

(3028308) Erythrocytes [#/volume] in Pleural fluid

334

1684

1.64

15.72

1.6

1.5

57195.09

64395.83

e6/l

0.18

197

1046

(3042517) Benzodiazepines panel - Urine

5.48

15.61

2.9

2.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

145

563

2.12

15.55

1.2

1.1

3.67

4.41

iu/ml

0.24

(40768806) Pleura Pathology biopsy report

320

1604

1.65

15.42

1.6

—

(3028300) Cannabinoids [Presence] in Urine

379

1983

1.58

15.34

3.5

1.9

—

(40768446) Kidney Pathology biopsy report

106

364

2.40

15.20

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

1076

6825

1.31

15.09

1.2

—

(3027008) Opiates [Presence] in Urine

377

1979

1.58

15.05

3.3

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

490

2724

1.49

15.04

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

266

1280

1.72

14.95

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

316

1597

1.64

14.76

1.6

0.87

g/l

0.02

231

1191

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

348

1803

1.60

14.70

2.5

2.1

6993.85

4934.05

u/l

0.49

101

682

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

981

6166

1.32

14.68

2.0

1.9

—

(3021788) Differential panel - Synovial fluid

393

2101

1.55

14.50

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

223

3128

0.58

14.49

1.7

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

130

498

2.15

14.46

5.7

6.4

25.07

24.90

mmol/l

0.15

119

442

(3016750) Collection duration of Urine

175

750

1.92

14.36

2.2

506.11

493.60

min

0.83

120

530

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

285

1414

1.66

14.32

1.3

509.92

501.71

u/l

0.02

271

1341

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

264

1284

1.70

14.29

3.3

3.4

7.46

11.74

nmol/l

0.46

257

1251

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

137

3.30

14.23

2.2

2.9

173.67

65.70

mg/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

286

1427

1.66

14.07

2.4

2.1

27.77

25.85

mg/l

0.21

393

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

189

841

1.85

13.85

1.4

1.5

—

(3027944) Amphetamines [Presence] in Urine

364

1938

1.55

13.70

3.1

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13527

107181

1.15

13.42

5.3

5.2

2.44

2.60

mmol/l

76.81

12129

97618

(3036782) Glucose [Moles/volume] in Pleural fluid

274

1374

1.65

13.25

1.4

6.65

6.26

mmol/l

1.39

249

1266

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

322

1687

1.58

13.03

1.1

—

(4062490) Immunoglobulin typing, IgG

211

990

1.76

13.03

1.5

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

151

640

1.94

12.85

2.3

2.4

524.50

499.69

e6/l

0.24

121

553

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

237

2.60

12.85

1.1

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

307

2.39

12.72

1.3

1.2

43.78

19.43

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

324

1715

1.56

12.56

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

209

990

1.74

12.51

1.5

1.4

0.43

0.44

g/l

0.09

145

675

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

341

1828

1.54

12.50

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

209

991

1.74

12.47

1.5

1.4

2.88

2.98

g/l

0.33

143

677

(3027135) IgG subclass 1 [Mass/volume] in Serum

209

991

1.74

12.47

1.5

1.4

6.98

7.02

g/l

0.05

146

671

(3012565) Volume of 24 hour Urine

136

564

1.99

12.34

2.4

2.2

1860.44

1951.14

0.43

113

493

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

164

725

1.86

12.33

1.9

2.0

—

(3045788) Cell count panel - Pleural fluid

276

1414

1.61

12.29

1.6

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

262

2.48

12.29

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

248

1237

1.65

12.29

3.3

60.40

57.91

0.95

209

1026

(40757494) Bilirubin.total [Moles/volume] in Blood

158

691

1.88

12.28

2.2

15.08

31.86

umol/l

1.35

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

225

1097

1.69

12.15

2.5

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

259

2.48

12.11

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

171

771

1.83

12.09

2.0

1.9

72.35

70.62

0.68

160

731

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

414

2.15

12.08

2.5

2.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

357

2.24

11.99

2.8

2.7

29.13

29.30

umol/l

0.05

270

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

3.21

11.94

3.9

2.4

0.19

0.45

u/field

2.24

123

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

237

2.53

11.88

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

191

896

1.76

11.85

1.8

1.6

29.31

26.81

u/ml

0.34

197

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

254

1287

1.63

11.85

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

396

2.16

11.84

2.2

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

396

2.16

11.84

2.2

2.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

153

671

1.88

11.81

3.8

3.7

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.48

11.80

1.4

1.1

1.38

1.03

u/field

0.68

(3007566) Smooth muscle Ab [Titer] in Serum

447

2565

1.44

11.75

1.1

1.2

168.71

107.64

titre

0.54

225

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

162

725

1.84

11.74

1.4

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

405

2281

1.47

11.74

1.7

369.44

284.84

mu/l

2.19

371

2075

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2212

15607

1.19

11.71

1.3

30.21

37.74

iu/ml

2.24

698

4858

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

3.12

11.68

4.0

5.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

243

1223

1.64

11.65

1.4

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

351

2.23

11.65

1.6

1.4

3440850.00

1243916.47

iu/ml

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

253

1287

1.62

11.63

1.4

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

255

2.45

11.57

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

260

2.44

11.56

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

671

4134

1.35

11.56

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

115

460

2.06

11.55

32.2

28.1

102.05

112.77

ug/l

1.55

102

391

(3009214) Lutropin [Units/volume] in Serum or Plasma

407

2304

1.46

11.50

1.4

10.58

9.10

u/l

1.24

318

1847

(3026250) Tacrolimus [Mass/volume] in Blood

100

381

2.16

11.39

40.4

31.8

6.99

7.32

ug/l

0.83

333

(3036603) Volume of Urine

164

745

1.81

11.35

1.5

1.6

1995.69

1860.92

0.98

159

718

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

313

1684

1.53

11.33

1.3

1.2

290.34

276.79

u/ml

0.36

203

1072

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

160

725

1.82

11.17

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

329

1798

1.51

11.09

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

129

3.06

11.08

4.6

5.6

50.19

61.36

ug/min

0.44

109

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

134

575

1.92

11.08

1.3

1.2

109.66

94.50

u/l

0.88

120

494

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

984

6436

1.27

10.91

2.4

23.08

23.58

au/ml

0.04

405

(3015171) Extractable nuclear Ab [Units/volume] in Serum

563

3409

1.37

10.87

1.2

0.37

0.94

u/ml

2.41

331

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

140

617

1.87

10.69

2.4

2.5

0.21

0.23

e9/l

0.61

120

552

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

896

5810

1.28

10.67

1.3

68.63

54.69

au/ml

0.62

329

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

214

1068

1.65

10.65

1.4

13.33

13.14

u/l

0.16

205

1026

(3022493) Free Hemoglobin [Mass/volume] in Plasma

119

498

1.97

10.60

1.2

4.5

69.69

560.18

mg/l

0.52

352

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

246

2.41

10.58

2.7

2.5

7.04

7.91

mmol/l

1.01

147

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

473

2796

1.40

10.58

1.6

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

206

1020

1.66

10.57

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

232

2.45

10.50

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

226

1149

1.62

10.46

1.5

1.7

—

(3003338) MCHC [Mass/volume]

11156

87824

1.12

10.38

36.1

20.1

331.09

332.63

g/l

54.10

11034

86938

(3017315) Amylase [Enzymatic activity/volume] in Urine

135

595

1.87

10.33

1.4

1.2

242.48

398.25

u/l

1.03

125

552

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

326

1806

1.49

10.32

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12646

100280

1.12

10.28

4.3

4.1

1.31

1.29

mmol/l

2.48

11203

90339

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

249

1303

1.58

10.24

1.3

0.64

1.58

nmol/l

0.61

239

1254

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

131

2.95

10.23

2.1

2.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

177

2.65

10.19

1.7

1.6

88.41

118.28

ug/l

1.54

149

(3010503) CD19 cells [#/volume] in Blood

143

645

1.83

10.18

2.3

2.4

0.26

0.43

e9/l

0.40

133

623

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

146

663

1.81

10.17

1.4

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

249

1309

1.57

10.05

1.3

0.39

0.27

nmol/l

0.34

116

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13156

104614

1.13

10.03

4.8

4.6

4.23

4.43

mmol/l

85.45

11839

95785

(3034770) Mitochondria Ab [Titer] in Serum

436

2567

1.40

10.01

1.1

1.2

609.00

911.57

titre

—

(3052592) Norovirus Ag [Presence] in Stool

243

2.37

9.96

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

230

1190

1.59

9.94

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

361

2059

1.45

9.88

1.5

1.3

35.69

42.10

u/l

0.52

316

1786

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

129

569

1.87

9.87

1.1

1.67

9.77

nmol/l

1.85

128

(3016650) Hepatitis A virus Ab [Presence] in Serum

286

1559

1.51

9.81

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

442

2620

1.39

9.76

4.9

3.4

30.29

29.73

mg/l

0.12

315

1686

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

345

1956

1.46

9.75

1.6

1.4

—

(3017704) Immunofixation for Urine

148

685

1.78

9.71

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

471

2825

1.38

9.69

1.6

20451.60

14231.59

e6/l

0.95

329

2066

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

219

1132

1.59

9.52

1.3

12.86

14.23

u/l

0.57

206

1050

(3010838) Calcium [Moles/time] in 24 hour Urine

285

1563

1.50

9.52

1.8

4.68

4.80

mmol/24h

0.21

250

1341

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

278

1517

1.51

9.51

1.8

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

280

2.23

9.47

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

312

1745

1.48

9.47

1.6

1.4

109.88

116.12

u/ml

0.44

403

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

169

821

1.70

9.37

1.8

1.6

—

(3011985) Renin [Units/volume] in Plasma

248

1328

1.54

9.27

1.5

1.4

64.88

63.23

mu/l

0.05

212

1178

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

535

3300

1.34

9.23

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

398

2.01

9.20

1.2

1.1

642.25

574.35

ng/l

0.04

111

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

542

1.85

9.17

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

282

1556

1.50

9.16

2.3

2.7

1077.33

794.39

u/ml

0.15

275

1531

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

125

560

1.84

9.15

1.3

32.48

26.39

u/l

0.66

112

473

(3002079) Sodium [Moles/time] in 24 hour Urine

399

2.00

9.14

1.2

165.38

169.83

mmol/24h

0.18

399

(3044941) Cell count panel - Synovial fluid

316

1789

1.46

9.03

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

120

533

1.85

9.03

1.4

64.37

63.87

0.05

433

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

133

610

1.80

9.03

1.5

1.6

7.30

7.12

u/l

0.05

109

486

(3005322) IgE [Units/volume] in Serum or Plasma

813

5323

1.27

8.99

1.4

1.3

252.39

266.92

u/ml

0.15

750

4922

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.79

8.95

1.1

1.2

2.90

1.00

u/field

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

412

2454

1.39

8.88

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

198

1017

1.60

8.87

1.2

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

339

1952

1.43

8.87

1.5

1.4

15.04

17.23

u/ml

0.13

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

138

2.74

8.83

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

324

1852

1.44

8.82

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

232

1240

1.54

8.77

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

220

1163

1.56

8.73

1.3

—

nmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

122

551

1.82

8.72

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

353

2055

1.42

8.70

1.6

1.7

3.76

4.41

iu/l

0.58

114

664

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

400

2381

1.39

8.67

1.3

1.2

34.14

34.17

u/ml

0.00

133

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

178

2.49

8.64

1.1

5.28

5.27

pmol/l

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

126

2.80

8.63

1.3

1.2

83.05

108.19

ug/l

0.66

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

451

2741

1.36

8.60

1.5

1.9

12.93

11.52

mg/l

0.70

415

2553

(21494890) Protein electrophoresis panel - 24 hour Urine

261

1439

1.50

8.55

1.8

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

209

2.36

8.54

2.0

912.65

2460.52

e6/l

0.55

116

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.41

8.53

1.2

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

628

4008

1.30

8.53

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2025

14549

1.16

8.45

1.3

1.2

12.50

13.30

u/ml

0.11

669

5382

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

133

623

1.76

8.44

1.3

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

183

935

1.61

8.41

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

335

1947

1.42

8.35

1.2

3.98

10.26

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

223

2.29

8.23

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

421

1.92

8.20

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

132

623

1.74

8.18

1.3

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

555

3505

1.31

8.17

1.1

1.92

5.72

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

371

2206

1.39

8.12

1.3

1.2

12.39

5.89

u/ml

0.35

231

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

236

1289

1.51

8.11

4.0

3.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

375

2235

1.38

8.10

1.3

1.2

8.07

6.51

u/ml

0.19

340

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

200

1056

1.56

8.03

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

200

1056

1.56

8.03

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

200

1056

1.56

8.03

1.4

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.49

8.00

3.5

2.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

209

1116

1.54

7.98

1.6

1.5

23.89

27.93

1.01

136

694

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.31

7.95

1.6

2.89

0.65

mg/l

1.00

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

133

635

1.72

7.93

1.9

16.87

16.65

nmol/l

0.11

118

601

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13000

103711

1.11

7.93

4.7

4.6

1.33

1.39

mmol/l

55.66

11632

94204

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.44

7.83

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

517

3257

1.31

7.77

1.6

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

366

1.96

7.77

3.3

2.4

—

(3003129) Base excess in Capillary blood by calculation

327

2.01

7.74

1.7

1.8

0.91

0.40

mmol/l

0.43

305

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.21

7.72

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

220

2.24

7.64

1.5

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

121

569

1.75

7.63

1.5

6.44

6.60

u/l

0.07

478

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

280

1603

1.44

7.63

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

187

985

1.56

7.61

1.3

1.2

—

42.33

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

227

1248

1.50

7.60

1.4

1.3

277.57

373.52

pmol/l

0.58

190

1034

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

136

662

1.69

7.59

1.6

1.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

105

474

1.82

7.58

1.5

1.4

2.81

2.56

0.14

392

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

262

1483

1.46

7.58

1.6

1.5

59.28

61.48

0.37

174

936

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

155

2.49

7.56

1.1

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

387

1.91

7.55

1.8

1.4

17.50

24.18

umol/l

1.70

370

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

475

2973

1.32

7.49

3.2

3.5

41.07

74.85

u/ml

4.07

456

2851

(3035880) pH of Pleural fluid

166

857

1.60

7.37

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

113

530

1.75

7.22

1.1

39.71

26.70

u/l

0.79

478

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

113

531

1.75

7.17

1.1

106.34

87.70

u/l

0.78

483

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.11

7.14

1.6

1.5

5.40

3.53

mg/l

0.41

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.11

7.14

1.6

1.5

2.87

3.14

mg/l

0.06

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.11

7.14

1.6

2.00

1.27

mg/l

0.32

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

315

1867

1.39

7.09

1.2

3.22

4.78

u/ml

0.44

149

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

233

2.15

7.08

2.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

150

765

1.61

7.03

1.3

596.67

463.85

titre

0.15

(4200892) Spirometry reversibility

1151

8020

1.19

7.01

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

176

933

1.55

7.00

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

152

2.43

6.92

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

347

1.92

6.91

1.1

1571.97

1516.51

miu/ml

0.15

347

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

139

700

1.63

6.86

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

117

564

1.71

6.81

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

124

2.58

6.79

1.2

—

81.79

—

(3051593) INR in Capillary blood by Coagulation assay

142

722

1.62

6.75

7.8

12.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

588

3839

1.27

6.75

1.1

174.09

198.68

titre

0.08

(3007463) Buprenorphine [Presence] in Urine

6.92

6.70

2.8

8.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

145

744

1.60

6.65

1.3

40.71

78.20

titre

1.60

(3016228) CD19 cells/100 cells in Blood

442

1.79

6.57

1.9

9.30

8.00

0.39

428

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

585

5971

0.80

6.54

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

143

737

1.60

6.46

3.5

2.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.94

6.41

3.1

1.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

158

2.34

6.39

2.4

3.8

42.41

40.97

umol/l

0.15

126

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

106

507

1.72

6.38

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

124

619

1.65

6.37

1.5

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

128

645

1.63

6.34

2.0

2.2

63.87

156.50

ug/min

1.41

161

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

154

812

1.56

6.32

1.0

675.92

721.15

ng/l

0.66

108

523

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.47

6.31

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

124

621

1.64

6.30

3.3

3.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

154

814

1.56

6.26

1.0

42.05

42.74

ng/l

0.08

108

531

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

207

2.14

6.26

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

115

2.57

6.23

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.95

6.22

1.2

13.55

14.18

pmol/l

0.05

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

120

2.53

6.22

1.3

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

338

1.87

6.16

2.2

2.0

9.70

11.25

0.39

306

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

214

2.11

6.15

1.6

1.5

10.54

9.09

0.16

102

(3013139) Helicobacter pylori Ag [Presence] in Stool

904

6242

1.20

6.12

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

153

813

1.55

6.09

1.0

354.29

334.59

ng/l

0.16

110

538

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

204

2.14

6.09

1.6

1.5

0.37

0.40

ug/l

0.19

121

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

206

1167

1.45

6.04

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1923

14088

1.13

6.02

4.6

4.7

32.79

32.42

0.72

1342

9555

(3004616) Nuclear Ab [Presence] in Serum

204

1155

1.45

6.00

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

443

1.75

5.99

2.6

2.3

51.63

53.68

umol/l

0.24

367

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.77

5.98

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

100

480

1.71

5.97

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.45

5.97

1.5

1.2

1.17

1.00

u/field

0.30

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

158

2.29

5.97

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

262

1.98

5.91

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

359

2239

1.32

5.91

1.4

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

367

1.81

5.89

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

614

1.62

5.87

1.6

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

139

730

1.57

5.84

2.5

2.4

693.52

587.79

e6/l

1.56

126

702

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

192

2.14

5.80

1.5

1.7

170.34

140.32

ng/l

0.46

192

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

457

2954

1.28

5.76

1.7

1.5

13.37

6.11

iu/ml

0.31

123

684

(3006270) Folate [Moles/volume] in Blood

182

1017

1.47

5.74

1.3

1.2

296.91

339.35

nmol/l

1.98

141

817

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

150

806

1.53

5.71

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

192

1086

1.46

5.70

1.4

1.3

1.40

1.42

nmol/l

0.08

165

989

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

120

613

1.61

5.68

1.6

1.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

132

690

1.57

5.68

2.0

1.9

9.59

8.79

umol/l

0.14

104

501

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.88

5.68

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

3.23

5.67

2.1

1.4

—

(3042733) HLA Ab [Presence] in Serum

295

1.89

5.67

5.4

4.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.42

5.63

7.1

9.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2038

15049

1.13

5.61

11.7

7.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

234

2.00

5.57

1.1

1.2

227.81

263.48

pmol/l

0.49

170

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

126

655

1.58

5.56

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.65

5.54

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

381

1.77

5.52

1.2

38.55

40.56

g/l

0.74

196

(40757373) Influenza virus identified in Isolate

258

1.94

5.49

1.2

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

651

1.58

5.48

1.2

—

(3028433) Virus identified in Specimen by Culture

365

1.78

5.42

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

237

1.98

5.39

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

125

654

1.57

5.38

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

125

654

1.57

5.38

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

385

1.75

5.34

1.6

8.64

10.77

nmol/l

0.10

322

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

2.40

5.29

1.1

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

429

1.71

5.29

2.0

1.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

124

651

1.57

5.27

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

124

651

1.57

5.27

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

136

2.30

5.24

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

268

1632

1.35

5.23

1.1

35.94

668.93

iu/ml

0.95

337

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

270

1652

1.35

5.12

1.3

1.2

37.00

39.09

u/ml

0.09

166

(3030313) Adrenal Ab [Titer] in Serum

3.44

5.12

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

404

2618

1.27

5.04

2.7

3.4

924.16

1102.88

u/ml

0.11

361

2403

(3000919) Neutrophils/100 leukocytes in Pleural fluid

436

1.68

5.01

1.4

23.93

20.80

0.46

387

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

151

838

1.48

4.99

1.4

1.3

24.19

24.94

u/l

0.11

119

695

(3020491) Glucose [Moles/volume] in Blood

149

828

1.48

4.90

2.3

2.1

7.20

7.11

mmol/l

0.12

110

565

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

281

1.84

4.88

1.2

1.3

138.42

129.32

nmol/l

0.15

208

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

293

1.82

4.88

2.8

3.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

105

2.43

4.84

1.5

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

152

2.16

4.82

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

226

1360

1.37

4.80

1.1

1.57

1.55

g/l

0.39

204

1222

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

154

868

1.46

4.74

1.1

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

138

762

1.49

4.71

1.1

1.2

36.75

45.57

u/ml

0.18

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

250

1.87

4.67

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.46

4.66

2.4

1.8

1.45

1.43

mmol/l

0.01

(3020650) Glucose [Presence] in Urine

233

1.90

4.65

2.1

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

286

1.81

4.64

1.2

1.5

291.25

152.19

nmol/24h

0.52

286

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

330

1.74

4.56

1.4

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

158

906

1.43

4.47

2.3

2.4

—

(1761868) Lipid panel - Serum or Plasma

3794

33131

0.92

4.43

3.6

3.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.40

4.29

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

144

2.11

4.24

1.4

1.6

41.67

47.88

pmol/l

0.26

117

(3034891) Synovial lining cells/100 cells in Synovial fluid

105

562

1.54

4.19

1.4

1.5

5.94

3.13

0.64

126

(3024869) Neuronal Ab [Presence] in Serum

213

1.89

4.16

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.78

4.10

1.5

1.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

11.49

4.07

1.1

1.0

—

(3014891) Appearance of Pleural fluid

215

1.87

4.06

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

125

2.17

4.06

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.31

4.04

1.2

2.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

102

548

1.53

4.02

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

333

2173

1.26

4.02

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.52

3.93

1.7

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

111

611

1.49

3.92

1.4

1.3

1.75

1.62

u/ml

0.06

352

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.61

3.85

1.0

—

(3033799) Differential panel - Peritoneal fluid

392

1.61

3.83

1.7

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

214

1327

1.33

3.83

1.3

1.2

3.98

3.86

u/ml

0.06

595

(3018851) Theophylline [Moles/volume] in Serum or Plasma

118

2.16

3.79

1.6

1.7

44.10

45.44

umol/l

0.11

118

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

731

5180

1.16

3.78

1.2

134.37

130.39

iu/ml

0.08

250

1818

(3028679) Herpes simplex virus Ab [Presence] in Serum

401

1.60

3.74

1.1

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

169

1.94

3.73

1.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

326

1.66

3.71

1.1

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

480

1.54

3.70

1.3

3.95

3.71

mmol/l

0.22

441

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

108

599

1.48

3.70

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

225

1413

1.31

3.69

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

488

1.53

3.65

1.7

2.2

99.43

95.77

0.49

462

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

285

2937

0.79

3.65

1.5

1.7

4.30

3.95

mg/l

0.17

229

2154

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

108

601

1.48

3.64

1.1

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

173

1049

1.36

3.61

1.2

1.1

2.86

1.82

iu/ml

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

126

2.09

3.61

4.0

3.2

1.34

1.26

mg/l

0.10

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

143

841

1.40

3.60

1.3

1.2

260.00

91.54

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

143

841

1.40

3.60

1.3

1.2

182.22

175.26

titre

0.04

154

(3039162) Centromere protein B Ab [Units/volume] in Serum

177

1078

1.35

3.60

1.3

1.2

60.64

43.03

u/ml

0.40

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

2.10

3.58

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

400

1.58

3.56

3.3

3.1

20.29

24.86

mu/l

0.73

372

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.68

3.56

2.8

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

287

1.69

3.53

1.3

1.4

56.27

45.32

g/l

0.13

219

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.25

3.52

1.7

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

121

695

1.43

3.49

1.1

288.51

286.37

mg/l

0.12

105

627

(44786800) Granulocytes/100 leukocytes in Body fluid

192

1.84

3.43

1.3

31.97

23.38

0.68

149

(3011544) Albumin [Mass/volume] in Pleural fluid

140

1.99

3.43

1.1

1.2

17.87

17.02

g/l

0.28

129

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.26

3.42

1.3

0.12

0.18

nmol/l

1.03

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.28

3.39

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

183

1135

1.33

3.32

1.4

1.3

183126.49

142773.32

e6/l

0.27

144

756

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.35

3.29

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.86

3.27

1.1

1.0

382.71

101.48

pmol/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

358

1.58

3.24

1.4

1.8

169.54

168.54

0.03

335

(3044007) Cell count panel - Peritoneal fluid

352

1.59

3.23

1.7

2.0

—

(3027874) Urate [Moles/volume] in Urine

2.95

3.20

1.1

1.73

1.72

mmol/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

144

1.94

3.19

1.5

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

191

1.81

3.19

1.5

1.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

197

1.79

3.19

1.3

1.2

48.25

136.95

titre

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

437

3015

1.19

3.17

2.1

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

1.98

3.17

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

485

1.49

3.17

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

485

1.49

3.17

1.6

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

476

0.53

3.12

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

649

1.42

3.12

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.19

3.09

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

333

2246

1.22

3.08

1.4

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.62

3.07

1.1

2.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

357

1.57

3.06

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

312

1.61

3.06

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

543

1.45

3.05

3.7

3.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

490

1.48

3.03

1.6

2.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.17

3.01

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.96

3.01

1.6

1.4

22.91

15.93

nmol/l

0.28

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

116

682

1.40

2.99

1.3

1.4

14.39

13.67

umol/l

0.47

108

637

(3000034) Microalbumin [Mass/volume] in Urine

165

1027

1.32

2.97

3.3

3.0

43.85

52.10

mg/l

0.31

136

735

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

227

1.70

2.94

1.3

1.2

0.85

47.49

mg/l

1.00

176

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3564

27761

1.07

2.93

1.7

1.6

1.40

1.34

mmol/l

3.31

2898

22850

(3001964) Herpes simplex virus Ag [Presence] in Specimen

297

1.60

2.91

1.2

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

340

2316

1.21

2.87

1.9

177.98

195.44

pmol/l

2.35

311

2147

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

470

1.47

2.85

1.3

87.92

337.38

ug/l

1.56

240

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.15

2.84

1.0

1.1

9.96

12.20

u/l

0.26

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

349

2388

1.20

2.82

2.0

1.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

300

1.59

2.81

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

326

2219

1.21

2.79

1.1

9.74

7.79

u/ml

0.18

218

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

2.74

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

358

0.50

2.71

1.3

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

356

1.52

2.68

1.4

23.45

21.98

0.14

306

(3041918) Cholesterol [Moles/volume] in Pleural fluid

272

1.60

2.67

1.2

1.54

1.55

mmol/l

0.01

172

(1002224) Polysomnography panel

339

3305

0.84

2.62

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

165

1729

0.78

2.55

1.6

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

321

1.54

2.55

1.2

—

(3048879) Bone marrow aspiration report

394

1.48

2.54

1.4

1.6

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.16

2.53

1.1

1.2

0.05

0.07

g/l

1.60

(3050129) First trimester maternal screen panel - Serum or Plasma

120

1310

0.75

2.53

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

350

2423

1.19

2.53

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

388

1.48

2.53

2.3

1.9

6513.66

13211.29

e6/l

0.59

215

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.46

2.52

1.3

334.73

347.50

umol/24h

0.07

(3023323) Follitropin [Units/volume] in Serum or Plasma

339

2344

1.19

2.49

1.4

25.71

26.63

iu/l

0.19

284

1986

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

151

956

1.30

2.47

1.1

93.70

96.54

0.67

135

898

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

151

956

1.30

2.47

1.6

1.8

4.53

4.17

mg/l

0.35

143

908

(3051101) Glucose [Moles/volume] in Cord blood

252

1.60

2.47

5.6

6.2

—

(3012898) Urea [Moles/volume] in Urine

105

1.96

2.46

1.4

1.3

119.10

173.68

mmol/l

2.21

(3013336) Amino acids [Identifier] in Serum or Plasma

5.47

2.46

1.0

2.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.01

2.45

1.2

1.3

—

mmol/l

—

(3024263) Appearance of Synovial fluid

104

625

1.37

2.43

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.86

2.42

1.3

1.2

1.80

2.07

mmol/24h

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

242

1.60

2.37

1.1

89.43

84.72

0.67

131

(3011335) Digoxin [Mass/volume] in Serum or Plasma

113

1.89

2.34

2.3

2.1

—

(3001556) Androgen free Index in Serum or Plasma

2.54

2.33

1.3

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

360

0.55

2.33

1.2

1.5

9.47

8.28

mmol/l

1.10

344

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

139

879

1.30

2.32

2.4

2.3

—

(40768443) Skin Pathology biopsy report

660

4824

1.13

2.31

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

128

801

1.31

2.31

1.1

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.04

2.30

1.2

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

290

1.53

2.29

1.2

1.3

113.89

112.62

0.13

256

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

205

1362

1.24

2.29

1.3

1.2

3.94

4.27

u/ml

0.08

458

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

181

1.68

2.28

1.2

1.3

73.65

248.73

u/l

0.51

132

(37021550) Renin [Units/volume] in Plasma --upright

219

1.61

2.28

1.2

1.3

52.93

71.70

mu/l

0.41

160

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

272

1861

1.20

2.27

1.2

1.3

217.72

216.88

miu/ml

0.01

738

(3024471) HLA-A [Type]

317

1.50

2.27

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

317

1.50

2.27

1.2

1.3

0.31

0.30

g/l

0.18

252

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

298

1.52

2.25

1.6

1.4

14.53

16.23

pmol/l

1.23

244

(40768441) Liver Pathology biopsy report

122

762

1.32

2.24

1.4

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.00

2.24

2.0

2.1

14.75

19.04

0.23

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

128

807

1.30

2.20

1.7

1.4

0.28

0.32

nmol/l

0.40

636

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

186

1232

1.24

2.16

1.5

189.21

163.13

pmol/l

0.18

181

1193

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.48

2.15

1.7

1.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

106

653

1.33

2.15

1.3

1.13

1.23

nmol/l

0.37

500

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

178

1.66

2.15

1.2

1.3

352.11

551.96

ng/l

0.17

126

(21491868) Cryoglobulin [Mass/volume] in Serum

363

1.45

2.11

1.2

0.25

0.13

g/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

189

1259

1.23

2.09

1.1

118.89

114.50

1.11

168

1130

(4146454) Self-monitoring of blood glucose

211

1422

1.22

2.09

2.8

2.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

124

1.79

2.08

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.98

2.07

1.3

1.2

—

(3034426) Prothrombin time (PT)

311

1.48

2.06

1.1

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.95

2.06

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

443

1.39

2.00

2.4

1.9

8266.00

3398.79

e6/l

0.28

311

(3000492) Spirometry study

1229

9349

1.08

1.99

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

257

0.51

1.98

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

128

822

1.28

1.96

1.2

9.87

9.10

mmol/l

1.02

121

776

(3033923) Metanephrine [Moles/time] in 24 hour Urine

196

1.59

1.96

1.2

0.71

0.69

umol/24h

0.10

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

195

1315

1.22

1.94

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

895

0.74

1.94

1.8

1.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.38

1.94

3.3

4.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

109

1.81

1.93

2.2

2.1

51.00

63.03

0.84

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

146

1.69

1.93

1.3

1.1

17.89

19.37

u/l

0.21

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.12

1.87

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

758

5660

1.10

1.87

1.7

1.6

—

(3024932) HLA-DR beta [Type]

312

1.45

1.85

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

312

1.45

1.85

1.2

3.62

3.93

umol/l

0.26

291

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

117

1.75

1.84

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1633

12599

1.07

1.83

1.5

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.99

1.82

1.3

1.2

—

(3001729) Color of Synovial fluid

100

1.81

1.79

2.0

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

942

8377

0.92

1.78

1.5

1.4

—

(3007147) Virus identified in Stool by Electron microscopy

4.10

1.75

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

463

1.35

1.73

1.4

7.27

9.43

ug/l

0.88

414

(3042010) Triglyceride [Moles/volume] in Pleural fluid

204

1.53

1.69

1.2

2.62

1.18

mmol/l

0.54

136

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

622

1.29

1.69

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.57

1.68

1.6

1.4

301.67

501.51

nmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

156

1556

0.82

1.67

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

238

1.48

1.67

1.1

1.2

92.95

81.16

1.84

131

(40768793) Breast Pathology biopsy report

133

1348

0.81

1.67

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

992

0.78

1.66

1.6

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

199

1.53

1.64

2.6

3.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

906

0.77

1.63

1.5

1.3

143.24

178.55

pmol/l

1.48

906

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.05

1.63

1.1

1.3

2838.00

2277.40

ng/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

122

1.68

1.63

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

260

1.45

1.62

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

450

1.33

1.56

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

107

699

1.26

1.50

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.92

1.49

3.5

3.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

385

2812

1.13

1.49

1.9

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

225

1.46

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.73

1.45

4.1

4.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

263

2471

0.87

1.42

1.5

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

146

994

1.21

1.41

1.1

2.67

3.68

u/ml

0.34

405

(3034092) Cytoplasmic Ig cells/100 cells in Blood

121

1.63

1.41

13.8

8.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.74

1.40

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.74

1.40

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

174

1.51

1.39

1.1

1.2

72.56

70.76

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

129

1282

0.82

1.39

1.2

1.1

1.38

1.79

u/ml

0.35

643

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

521

0.72

1.38

1.2

1.3

1.48

1.53

g/l

0.58

521

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

140

952

1.21

1.38

1.5

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

148

1.55

1.37

1.4

1.1

8.99

8.21

mg/l

0.15

139

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

148

1.55

1.37

1.2

42.16

43.74

mg/l

0.07

126

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

366

0.67

1.37

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.88

1.33

1.6

1.8

1.29

1.42

umol/l

0.51

(3038177) Helicobacter pylori Ab [Presence] in Serum

199

1402

1.17

1.33

1.4

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

702

0.77

1.31

1.1

1.0

0.09

0.24

u/ml

1.11

215

(3047007) Chlamydophila sp Ab [Presence] in Serum

163

1134

1.18

1.28

1.3

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.85

1.27

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

173

1.47

1.22

1.8

1.2

36.75

47.12

—

(46235168) Fasting glucose [Moles/volume] in Blood

120

1.57

1.21

2.2

3.0

7.65

7.49

mmol/l

0.12

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

756

0.79

1.19

1.4

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.05

1.19

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

174

1.46

1.19

1.1

1.2

86.38

80.20

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

118

1160

0.83

1.18

1.2

7.80

7.69

mmol/l

0.16

102

971

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.89

1.17

1.1

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

379

1.30

1.16

1.6

1.3

65.30

58.77

0.82

320

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.56

1.16

3.4

3.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

176

1.45

1.14

1.3

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.92

1.12

1.3

1.1

253.45

257.25

nmol/l

0.02

(3022689) Creatine [Moles/volume] in Urine

267

1.35

1.12

1.6

1.4

—

(3007916) DNA double strand Ab [Titer] in Serum

104

1.58

1.09

1.1

1.2

—

81.70

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

2.41

1.08

1.4

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

333

1.31

1.08

2.2

1.3

13.97

12.88

g/l

0.38

252

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.82

1.06

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

179

1.42

1.06

1.4

62.11

71.72

0.80

155

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

179

1279

1.15

1.05

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

117

808

1.19

1.05

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

307

1.31

1.03

1.1

—

(3016135) IgD [Mass/volume] in Serum

2.28

1.01

1.2

1.0

80.62

36.63

mg/l

—

(3009871) Measles virus Ab [Titer] in Serum

256

0.67

1.01

1.5

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

181

1.41

1.00

1.2

1.1

0.29

1.18

u/ml

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

826

0.82

0.99

6.3

3.1

13.44

13.21

1.36

815

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

128

1.48

0.96

1.1

19.55

17.61

iu/ml

0.07

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.81

0.96

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

190

1.38

0.95

1.0

1.2

—

(21494434) Karyotype in Bone marrow

164

1177

1.14

0.93

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

856

0.83

0.93

1.1

2.48

3.04

u/ml

0.18

407

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

104

721

1.18

0.92

4.9

5.0

172.30

82.37

u/ml

0.25

219

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.57

0.92

1.3

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

284

1.30

0.92

2.3

2.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.14

0.91

11.3

6.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

429

3253

1.08

0.90

1.9

1.7

45.54

44.32

nmol/l

0.42

405

3121

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.60

0.88

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

352

1.26

0.87

14.9

7.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.70

0.87

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

388

0.76

0.87

1.1

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.74

0.86

2.5

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.78

0.85

1.1

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

1180

1.13

0.84

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

119

1128

0.86

0.84

1.1

4.07

4.15

u/ml

0.02

553

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

385

1.24

0.82

1.2

1.8

189035.14

17908.04

u/ml

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.70

0.81

2.5

1.4

—

(3000285) Sodium [Moles/volume] in Blood

161

1.38

0.81

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.72

0.76

1.0

1.1

4.26

0.07

mg/l

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

375

1.23

0.75

5.2

5.5

69.83

70.04

0.02

305

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.85

0.74

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.05

0.73

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.64

0.73

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

354

1.23

0.73

1.1

4.42

4.36

u/ml

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.64

0.73

1.0

1.1

37.36

36.84

0.13

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.64

0.73

1.0

1.1

20.91

20.86

0.01

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.64

0.73

1.0

8.51

8.14

0.16

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

572

1.18

0.73

3.0

2.7

209.85

204.21

u/l

0.24

565

(3018291) Platelet Ab [Presence] in Serum

1.95

0.71

1.0

1.1

—

(3008607) Semen analysis panel

1.95

0.71

1.6

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.69

0.69

5.4

6.1

648.71

437.38

umol/l

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.69

0.69

2.6

1.2

0.50

0.35

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.69

0.69

1.3

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

308

0.77

0.67

1.2

1.0

0.37

1.42

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

262

1.25

0.67

1.8

1.5

10.41

9.19

ug/l

0.94

262

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

158

1166

1.11

0.65

1.1

9.97

13.63

au/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

107

997

0.88

0.64

1.2

1.1

1.12

1.30

u/ml

0.15

489

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.54

0.64

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

279

1.24

0.63

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

134

1.35

0.62

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

134

1.35

0.62

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

134

1.35

0.62

1.0

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.41

0.61

1.3

2.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.60

0.61

1.1

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.56

0.61

6.8

4.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

229

1.25

0.60

2.1

2.0

9.16

9.03

mg/l

0.04

183

(3034614) HLA Ag [Interpretation]

0.00

0.60

0.0

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

274

1.23

0.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

274

1.23

0.59

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

274

1.23

0.59

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

274

1.23

0.59

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.59

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.62

0.58

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

297

1.22

0.58

16.2

7.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.49

0.57

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

532

0.85

0.57

4.5

5.1

56.67

565.05

u/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

1.46

0.56

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

643

1.14

0.55

3.1

2.6

40.33

36.88

0.89

367

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

286

1.21

0.53

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

251

0.78

0.53

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

453

1.16

0.52

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

110

0.67

0.52

1.2

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

158

0.73

0.52

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

119

1082

0.90

0.51

1.1

0.88

u/ml

0.00

449

(44813793) Dust mix specific IgE antibody measurement

562

1.14

0.51

1.1

—

(3019174) dRVVT (LA screen)

1.42

0.50

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

213

1.23

0.50

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

228

1.22

0.50

1.9

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

349

1.18

0.49

1.1

—

(4281824) Cell count and differential, peritoneal fluid

112

828

1.11

0.49

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

118

875

1.11

0.49

1.5

1.4

—

(40765096) Chromosome analysis panel by Banding

380

1.17

0.49

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.48

1.1

1.2

1.76

1.84

umol/24h

0.07

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

511

1.14

0.48

6.3

6.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.48

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

170

1.26

0.48

2.0

1.8

2.15

2.13

ug/l

0.01

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

222

1.22

0.48

1.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

351

1.17

0.47

1.2

1.0

0.40

2.17

u/ml

1.05

113

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

583

1.13

0.46

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.35

0.45

3.7

4.5

—

(3005033) Fetal Nuchal fold Thickness US

117

872

1.10

0.45

1.5

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

281

0.82

0.45

1.6

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.47

0.45

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

531

1.13

0.44

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.58

0.42

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.37

0.42

2.2

2.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.41

0.42

1.7

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.52

0.41

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.41

0.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

339

2924

0.95

0.40

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

139

1053

1.08

0.40

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1291

10852

0.97

0.39

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

145

1.25

0.39

1.0

1.3

464714.55

154554.61

nmol/l

0.27

121

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

139

1054

1.08

0.39

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

355

0.85

0.39

1.2

1.0

0.53

0.99

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.42

0.39

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

675

0.90

0.38

1.8

1.5

0.95

0.92

g/l

0.26

669

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

138

1049

1.08

0.37

1.5

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

794

0.91

0.37

1.1

2.95

3.49

u/ml

0.21

322

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

138

1053

1.08

0.35

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

581

1.10

0.34

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.33

0.33

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

244

0.84

0.33

1.1

1.2

—

503.33

—

(3008898) HLA-B27 [Presence]

319

2504

1.05

0.33

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

143

1.21

0.30

1.3

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.26

0.30

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

222

0.85

0.28

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

231

1985

0.95

0.28

1.6

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

145

1.19

0.27

1.4

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

117

901

1.07

0.26

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

443

1.09

0.25

1.2

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

120

1043

0.94

0.24

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.28

0.23

1.0

2.3

1.58

33.38

pmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

1.25

0.23

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.28

0.23

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.23

0.22

1.1

0.00

0.98

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.24

0.22

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.24

0.22

87.4

11.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

456

0.92

0.22

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

439

1.08

0.21

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.17

0.21

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.20

0.20

1.0

1.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

135

1.16

0.19

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

247

0.90

0.18

2.9

3.2

7.28

6.96

mg/l

0.08

203

(3029396) Erythrocyte agglutination [Presence] in Blood

128

1.15

0.18

2.3

2.7

—

(40762814) Titanium [Mass/volume] in Blood

247

1.10

0.16

2.3

3.10

3.17

ug/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

482

0.94

0.16

1.0

10.00

10.59

iu/ml

—

115

(3045462) Protein/Creatinine [Ratio] in Urine

1.15

0.15

3.9

5.5

155.53

57.13

g/mol

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.09

0.14

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.09

0.14

1.1

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

321

1.07

0.14

1.4

1.2

41.38

32.61

0.78

213

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

114

0.86

0.13

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

117

926

1.04

0.13

1.8

2.0

4.61

3.40

ug/l

0.45

106

846

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

371

1.06

0.12

1.1

99.90

95.11

0.42

287

(3025130) Human papilloma virus identified in Specimen

652

0.96

0.12

1.6

1.7

—

(4212803) Bone marrow aspirate examination

130

0.88

0.12

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

123

1042

0.97

0.11

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

143

1140

1.03

0.11

1.6

1.5

—

(4034850) Laboratory test

467

3776

1.02

0.11

14.5

10.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

518

1.05

0.11

1.2

1.1

1.11

1.08

ratio

0.26

180

(3025577) Chromium [Mass/volume] in Blood

113

898

1.03

0.10

2.0

2.94

2.02

ug/l

0.64

748

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

415

0.95

0.10

2.1

1.9

17.96

519.16

ug/l

1.24

392

(3005011) Chlamydia sp Ab [Titer] in Serum

118

1.11

0.10

1.7

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

286

1.06

0.10

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

119

0.90

0.09

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

127

1.10

0.09

1.7

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

530

1.04

0.08

1.3

1.4

3.10

4.17

ug/l

0.88

460

(3022475) Manganese [Moles/volume] in Blood

1.03

0.08

1.2

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

112

1.10

0.08

1.1

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

233

1.06

0.07

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.04

0.07

1.4

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

145

1.08

0.06

2.1

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.12

0.06

1.5

2.7

—

(40768795) Lymph node Pathology biopsy report

129

1039

1.02

0.06

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

430

1.03

0.05

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

148

0.94

0.04

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

246

1.03

0.03

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

179

0.96

0.02

1.2

1.0

3.68

11.04

u/ml

—

101

(3009015) Lactate [Moles/volume] in Synovial fluid

129

0.95

0.01

1.3

6.87

6.71

mmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.06

0.01

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

241

1.02

0.00

1.4

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

374

0.99

0.00

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

124

0.99

0.00

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

176

1.03

0.00

1.0

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.03

0.00

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.05

0.00

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

185

1.02

0.00

2.1

1.8

—

(40758292) HTLV I+II Ab panel - Serum

150

0.98

0.00

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

177

1.02

0.00

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

251

1.01

0.00

6.6

7.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

291

1.02

0.00

1.2

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.01

-0.00

11.0

9.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.94

-0.00

1.3

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

36.71

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.91

-0.00

1.8

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.93

-0.00

1.4

1.3

1.38

1.33

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

27.12

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint R18_RETEN_URINE and mortality.

Females

Parameter	HR [95% CI]	p-value
R18_RETEN_URINE	2.114 [1.91, 2.34]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.019

During the follow-up period (1.1.1998 — 31.12.2019), 8761 out of 23480 females with R18_RETEN_URINE died.

Males

Parameter	HR [95% CI]	p-value
R18_RETEN_URINE	1.954 [1.76, 2.17]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 37950 out of 77816 males with R18_RETEN_URINE died.

Mortality risk

Mortality risk for people of age

years, who have R18_RETEN_URINE.

N-year risk	Females	Males
1	0.165%	0.372%
5	1.217%	1.993%
10	2.776%	4.779%
15	5.002%	8.751%
20	8.499%	14.307%

Relationships between endpoints

↥

Index endpoint: R18_RETEN_URINE – Retention of urine

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Retention of urine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints